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H] Sc tritium labelled scopolamine (antagonist of mAChRs) 
µOR µ-opioid receptor 
ACh acetylcholine (agonist for muscarinic acetylcholine receptors) 
Are arecoline (agonist for muscarinic acetylcholine receptors) 
BCh Bethanechol (partial agonist for muscarinic acetylcholine receptors) 
BQCA Benzyl quinolone carboxylic acid (positive allosteric modulator for muscarinic 
acetylcholine receptors) 
cAMP cyclic adenosine monophosphate 
CCh carbachol (synthetic agonist for mAChRs) 
Cer Cerulean (a variant of eCFP) 
CFP cyan fluorescent protein (eCFP: enhanced CFP) 
DAMGO [D-Ala2, N-Me-Phe4, Gly5-ol]-Enkephalin acetate salt (µOR peptide agonist) 
DMEM Dulbecco’s Modified Eagle’s Medium 
EC50 half-maximal effective concentration (concentration-response curves) 
ETbR Endothelin b receptor 
FCS fetal calf serum 
FRET Förster/Fluorescence Resonance Energy Transfer 
FSK forskolin 
Gal Gallamine (negative allosteric modulator for muscarinic acetylcholine receptors) 
GDP guanosine 5′-diphosphate sodium salt 
GFP green fluorescent protein 
GPCR G-protein-coupled receptor 
G-protein guanine nucleotide binding protein  
GTP guanosine 5′-triphosphate sodium salt 
GTPγS guanosine 5′-[γ-thio]triphosphate tetralithium salt 
HEK human embryonic kidney (cell line; used in this study: HEK293T) 
HRP horseradish peroxidase 
Ipx Iperoxo 




koff  constant of dissociation 
M1-R type 1 muscarinic acetylcholine receptor  
M2-R type 2 muscarinic acetylcholine receptor  
M3-R type 3 muscarinic acetylcholine receptor  
M4-R type 4 muscarinic acetylcholine receptor  
M5-R type 5 muscarinic acetylcholine receptor 
mAChRs muscarinic acetylcholine receptors 
MCh methacholine 
NA noradrenaline (agonist for α2A-AR and β-AR) 
NAM negative allosteric modulator 
PAGE polyacrylamide gel electrophoresis 
PAM positive allosteric modulator 
PBS phosphate buffered sodium (buffer) 
Pilo Pilocarpine 
PKA protein kinase A 
PLC phospholipase C 
RAMP Receptor activity-modifying protein 
RT room temperature (25  C) 
S.E.M. standard error of the mean 
SDS Na
+
 dodecyl sulphate 
TP-R thromboxane A2 receptor 
U46619 9,11-Dideoxy-11α,9α-epoxymethanoprostaglandin F2α (synthetic agonist for TP-R) 
wt wild-type 
YFP yellow fluorescent protein 
α2A-AR α2A-adrenoreceptor 
β1-AR β1-adrenergic receptor  





1.1 G-protein-coupled receptors (GPCRs) 
 G protein coupled receptors are transmembrane proteins consisting of external N-
terminus, 7 transmembrane helices, 3 extra- and 3 intracellular loops, and internal C-terminus. 
When activated by specific ligand they couple to heterotrimeric G proteins which transduce 
the conformational change of the receptor to the further signalling pathways. GPCRs 
represent the largest receptor family accounting for more than eight hundred members 
(Fredriksson et al. 2003) and, thus, are involved in many physiological functions. Since more 
than 30% of approved drugs on the market target GPCRs (Insel et al. 2018), the molecular 
mechanisms of G protein mediated signaling are of great interest. 
Apart from binding and activating G proteins, GPCRs can undergo phosphorylation by 
recruiting G protein coupled receptor kinases (GRKs) in an agonist dependent manner. 
Furthermore, phosphorylated and agonist activated receptors are recognized by arrestins, 
which induce receptor desensitization, internalization and potentially activate non-canonical 
signalling pathways including, MAP kinase and RhoA activation (X. Zhang and Eggert 2013). 
Moreover, GPCR can be modulated by RAMPs. These proteins can modify not only the 
specificity of the receptor-G protein interaction but also receptor trafficking (Booe et al. 
2015). 
1.1.1 Investigated GPCRs 
1.1.1.1 Muscarinic acetylcholine receptors (mAChRs) 
Historically, muscarinic acetylcholine receptors were named after alkaloid muscarine 
isolated from Amanita muscaria, the application of which led to selective mAChRs activation. 
The inhibitors of muscarinic receptors derived from belladonna alkaloids, such as 
scopolamine and atropine have been broadly used in medicine since medieval ages (Aronstam 
and Patil 2009). 
Muscarinic acetylcholine receptors belong to class A (rhodopsin-like) GPCRs and 
constitute a family with 5 subtypes (Gudermann et al., 1996). Stimulation of M5-R, M3-R and 
M1-R activate Gq protein leads to an increase of IP3 production and Ca
2+
 concentration within 
a cell (Caulfield 1993). M3 receptors are mostly expressed in smooth muscles, particularly in 
trachea, urinary bladder, and iris, as well as in glands, such as salivary glands (Gautam 2004) 
and pancreatic ß-cells (Gautam et al. 2007)(Eglen and Watson 1996), whereas M1-Rs and M5-
Rs are mostly involved in the transduction of cholinergic signals in the central nervous system 
and autonomic ganglia. They are present in several brain regions and big blood vessels. 
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Activation of M1-R or M5-Rs might lead to increased gastric acid secretion (via V. nerve) and 
vein contraction (Jürgen Wess 2004).  
In contrast to odd-numbered receptors, M2-R and M4-R members of the muscarinic 
receptor family couple to Gi proteins, which results in the inhibition of adenylyl cyclase and a 
drop in cytosolic cAMP levels (Caulfield 1993). M4-R is present in lungs and responsible for 
NO-dependent smooth muscle relaxation. M2-muscarinic receptors are expressed in heart 
tissues and autonomic nerve endings. Activation of these receptors lead to a negative 
inotropic and chronotropic effect, as well as reduced noradrenaline release (Brodde and 
Michel 1999). 
Due to such expression diversity in a variety of different tissues, mAChRs regulate many 
important physiological processes, which has allowed these receptors to stay in the focus of 
pharmacological interest for years. Although, muscarinic receptor ligands are broadly 
represented on the pharmaceutical market, even recently launched drugs still expose adverse 
reactions and have a narrow treatment window. Therefore, an improvement in the chemical 
and pharmacological properties of cholinergic drugs is necessary. 
In this study, we initially decided to focus on muscarinic receptors as a well-established 
and broadly investigated GPCR model due to the high homology of this receptor family. As 
has been mentioned above, M1-and M3-Rs are classic Gq coupling GPCRs (Dippel et al. 1996; 
Berstein et al. 1992; K. Leach et al. 2012; Smrcka et al. 1991). However, changes in the 
concentration of second messengers after treatment with Pertussis and Cholera toxins (Dippel 
et al., 1996; Zang, et al., 2011; Burford, et al., 1995; Wess,1993; Burford et al., 1996; 
Ramachandran et al., 1989) suggest a possible coupling to Gi and Gs proteins. In contrast, M2-
R is a classic Gi family coupled receptor (Leach, et al., 2012; Wess, 1993; Dell'Acqua, et al., 
1993). Despite the fact that mAChRs couple to different G protein classes, the comparison of 
crystal structures of these GPCRs revealed only small differences in transmembrane helices 
(Thal, et al., 2016; Haga, et al., 2012; Albert et al., 2002) meaning that the current knowledge 
of receptor structures does not allow for a prediction of the coupling to a particular G protein 
class or subtype (Wess, 1998; Wong, , 2003). However, recent cryo-EM structures of M1-R 
and M2-R with G proteins resolve conserved motifs and residues to be important for GPCR-G 
protein specific interaction. In particular, receptor C-terminal polybasic cluster and extended 
TM5 helix, as well as several residues of G protein α5 helix are shown to play a significant 




1.1.1.2 Adrenergic receptors 
Adrenoceptors are the most thoroughly studied GPCRs. Being broadly expressed in 
cardiovascular and both central and peripheral nervous systems, adrenergic receptors are 
involved in the whole body homeostasis (Ahles and Engelhardt 2014). They are subdivided 
into three groups: α1-ARs, α2-ARs and β-ARs (Bylund et al. 1994).  
The β1-AR functionally dominates over other adrenergic receptors expressed in a heart, 
regulating excitation-contraction of the myocardium (Dorn 2010). The β2 adrenergic receptor 
was the first specifically characterized GPCR from the group of adrenergic receptors, and 
known to play an important role in the cardiovascular and respiratory system (Reihsaus et al. 
1993). Its ligands are broadly used in clinics to treat pathological conditions associated with 
hypertension, asthma and chronic obstructive pulmonary conditions. Since approximately 
30% of the total adrenergic receptors expressed in the myocardium are β2-AR, the question of 
β2- and β1-ARs drug selectivity is quite acute for the pharmaceutical modulation of cardiac 
function and failure (Baker 2010; Lymperopoulos, Rengo, and Koch 2013). Both β1- and β2-
ARs bind to stimulatory G proteins and modulate intracellular Ca
2+
 via an increase in cAMP 
levels (R. A. Cerione et al. 1985). 
In contrast to β1-and β2-ARs, β3-adrenoceptor was the last to be cloned and is less 
studied. It is expressed in several parts of the gastrointestinal system, adipose tissue and 
kidney (Krief et al. 1993). Therapeutic agents targeting β3-adrenoceptor have only recently 
been launched on the pharmaceutical market (Ahles and Engelhardt 2014). 
All three isoforms of α2-ARs:  α2A-, α2B-and α2C- ARs bind to Gi family proteins (Ahles 
and Engelhardt 2014). This subtype of the adrenergic receptors contributes to insulin 
secretion, effects blood pressure, lipolysis, and is involved in neurotransmitter release (Knaus 
et al. 2007). 
Being associated with Gq proteins, activation of α1-ARs induces smooth muscle cell 
contractions and regulates blood pressure. Furthermore, α1-ARs are expressed in central and 
peripheral nervous systems where they control the neurotransmitter release (Piascik and Perez 
2001). 
In this study α2A-AR, β1-AR and β2-AR were investigated in terms of G protein 
selectivity.  
1.1.1.3 Thromboxane A2 receptors 
The thromboxane A2 receptor was the first GPCR cloned from the family of prostanoid 
(TP) receptors. Historically, the role of TP-R was associated with blood cell function. 
Nowadays, its expression was identified in a variety of tissues such as vascular smooth 
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muscle cells (Halushka 2000), platelets, airways and cardiomyocytes (Coleman, Smith, and 
Narumiya 1994). The physiological role of TP receptors is rather broad: platelet aggregation, 
closure of umbilical vessels at birth, wound healing and scar formation, modulation of the 
filtration rate in kidney and gastric secretion (Remuzzi, Fitzgerald, and Patrono 1992). 
Moreover, TP-receptor ligands have been found to be experimentally effective in the study of 
different myocardial perfusion disorders, hypertension, and the pathophysiology of 
cardiopulmonary and circulatory diseases (Halushka 2000).  
Activation of TP-Rs leads to intracellular Ca
2+
 mobilization via Gq protein (Shenker et al. 
1991). However, IP3-independent signalling and the absence of PTX or CTX treatment effect 
indicates the interaction of these GPCRs with G12/13 family proteins (Knezevic, Borg, and Le 
Breton 1993). It has been shown that stimulation of TP-R with thromboxane synthetic 
analogue U46619 induces platelet aggregation through G13 protein-dependent signalling 
pathways (Moers et al. 2003), whereas receptor interaction with G12 protein has been reported 
to play an important role in vasoconstriction (Offermanns et al. 1994; L. Zhang, Brass, and 
Manning 2009). The G12/G13 proteins-induced Rho/Rho kinase is a potential pharmacological 
target due to its involvement in various pathological processes such as malignant cell 
proliferation and metastasis (Worzfeld, Wettschureck, and Offermanns 2008; Kelly et al. 
2006). Due to the adverse reactions caused by wide expression and involvement in 
cardiovascular homeostasis the TP-R ligands are rather unpopular on the pharmaceutical 
market. Although only one drug was approved for asthma and severe allergy treatment 
(Horiguchi et al. 2002), the interest of TP-R antagonists as an alternative to NSAIDs is very 
high. 
1.1.1.4 Endothelin receptors 
Endothelin receptors are important in vascular resistance, cardiac output, and renal 
vasoconstriction (Leung et al. 2002). Therefore, these receptors are of great interest for 
hospital medicine being targets for the treatment of acute pulmonary states (Filep et al. 1994) 
and anaphylaxis reactions (Richter, Cloutier, and Sirois 2007). Endothelin receptors are 
subdivided into two types: ETAR and ETBR. In this research project we focused on ETRB as a 
GPCR which can bind to two G protein classes: Gi and Gq family (S. Liu et al. 2003), being a 
suitable agent to expand the mAChR-G protein binding model, described previously. In 
comparison to M1- and M3-Rs, ETBR has been shown to exhibit less potent Gq coupling when 
compared to Go (Doi et al. 1999). However, the experiments on the co-expression of different 
G proteins with ETRB and measurements of second messenger concentrations also suggest Gs 
and G13 binding (Takigawa et al. 1995; B. Liu and Wu 2003). Interestingly, several studies 
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suggest agonist-dependent selectivity of G protein coupling to ETBR as well as ETARs 
(Shraga-Levine and Sokolovsky 2000). 
1.1.1.5 Opioid receptors 
Opioid receptors (ORs) are expressed in nociceptive neural circuit and also in regions of 
the central nervous system related to reward and emotion systems (Al-hasani and Bruchas 
2011). There are four classes of opioid receptors reported so far: mu (), delta () and kappa 
() and opioid receptor like-1 (ORL1). Only a single gene was identified for each of the 
classes (Pasternak and Snyder 1975). Opioid receptors can form homo- or heterodimers and 
activate different G-protein dependent pathways. Binding of the agonist to the opioid receptor 
triggers Gi family protein activation leading to the inhibition of adenylyl cyclase and 
following a decrease in cAMP. Moreover, -subunits derived from Gi-protein directly 
enhance the activity of the inward rectifying potassium channel Kir3, which causes 
hyperpolarization of the neuronal cell and induces inhibition of action potential formation. 
Another important effect of the opioid-receptors is the inhibition of transmitter release by 
G-mediated inhibition of presynaptic NPQ-type CaV-channels (Al-hasani and Bruchas 
2011).  
Opioids, such as morphine or codeine, are natural and synthetic opioid receptors ligands. 
They differ by chemical structure which influences their efficiency and affinity to the 
receptor. Some of the opioids have a high selectivity level and bind strongly only to one of the 
receptor class, whereas others have a low affinity to all of the opioid receptor types. 
Moreover, endogenous opioids have been discovered. Already in 1975 researchers sequenced 
the first endogenous opioid, enkephaline (Hughes 1975), followed by the discovery of two 
more opioid peptides, dynorphin A and -endorphine. Enkephalines have been associated 
with the δ-opioid receptors, whereas dynorphine A shows a high affinity to κ-opioid receptors 







enkephaline) is known as a full µ-OR agonist and commonly used in 
pharmacological experiments (Pasternak and Pan 2013). 
Although opiates are used to treat pain and pain associated disorders (Pasternak and Pan 
2013), such as post-operative pain and cancer, in all cases the induction of addiction when 
used frequently is a major problem. Therefore, opioids have been listed on various 
„Substance-Control Schedules“ and can only be used under supervision of medical specialists. 
Additionally, regular usage of opiate may cause analgesia - an insensibility to feel pain 




1.2 Heterotrimeric G proteins  
G proteins or GTP-binding proteins represent the most common signalling system in 
human cells. They transduce the change in the GPCR conformation across the membrane into 
intracellular responses and are involved in many different signalling cascades, such as 
regulation of ion-channel open probability, kinase mediated protein phosphorylation and 
alteration of protein expression levels. Thus, G protein signalling pathways modulate many 
cellular functions including cellular excitability, cell contractions, chemotaxis, cell migration 
and cytoskeletal changes (Goh and Pennefather 1989).   
 G proteins are heterotrimeric and consist of three functional subunits: Gα (39-52 kDa), 
Gβ (35-36 kDa), and Gγ (7-10 kDa). Both Gα and Gβγ-subunits have a lipophilic membrane 
anchor. Independent of the heterotrimeric isoform composition, the Gα subunit carries the 
nucleotide-binding site. The GDP-bound form of Gα is inactive and associated with Gβγ 
subunits. GPCRs triggers the activation of G proteins by increasing the probability of the 
nucleotide-binding site to be in the “open” conformation (T. Flock et al. 2015). Exchange of 
GDP to GTP leads to G protein activation due to a reduced affinity of Gα towards 
G(Mixon et al. 1995; Lambright et al. 1996; Van Eps et al. 2011), resulting in subunit 
dissociation or rearrangement (Bünemann, Frank, and Lohse 2003). Both activated Gα and 
Gβγ subunits independently interact with their downstream effectors (Gilman 1987; Iniguez-
Lluhi, Kleuss, and Gilman 1993). The G protein cycle is completed when GTP is hydrolysed 
to GDP (Goricanec et al. 2016). 
The variety of different techniques such as cloning or genome sequencing, led to the 
discovery of genes encoding ɑ, β and ɣ subunits of heterotrimeric G proteins. Whereas the 
GPCRs family is extremely large, only 16 genes encoding 21 Gɑ subunits, 5 genes encoding 5 
Gβ (Hurowitz et al. 2000) and 12 genes encoding Gγ are known (Downes et al. 1999). 
However, the variety of feasible heterotrimeric combinations is quite broad and possibly 
important for the specificity of signal transduction across the membrane (Hildebrandt 1997). 
G protein isoforms are grouped into 4 major G protein classes (Table 1), defined by the type 
of Gɑ subunits: Gs, Gɑi, Gɑq/11 and Gɑ12/13 (Hamm 1998). Different Gɑ subunits regulate 




Table 1. G protein classes and homology of G subunits 
 
Table 1: Diversity of Gα subunits, modified from Simon et al. 1991; Syrovatkina et al. 2016. 
Homology of Gα proteins is shown as a diagram on the left of the table. The scale below the 
diagram depicts the percentage of similarity in amino acid sequence between different 
mammalian Gα subunits. No splice variants of Gs proteins are shown. The respective G 
protein classes defined by the type of the Gα subunit are given in the table on the right. Each 
of the four G protein classes is characterized by the effector, 2
nd
 messenger, and the GPCR it 
couples to. 
 
1.2.1 Gα subunit 
The Gα subunits share between 70 and 80% sequence identity and almost 100% 
structural similarity (Table 1) for all G protein classes as well as among mammalian species 
(Kaziro et al. 1991). This subunit consists of a helical domain and a nucleotide-binding 
domain. The latter one is highly conserved for all G protein superfamily and contains the 
nucleotide-binding site, which is important for the nucleotide exchange and functional role of 
the G protein. The nucleotide binding domain also mediates the association of Gα subunit 
with Gβ. These contacts are formed between β2, β3 strands of Gβ and α2 helix of Gα, and 
between the N-terminus helix of Gα and β-propeller structure (Wall et al. 1995). Due to the 
myristoylated N-terminal of Gα (Maurine E Linder et al. 1991) nucleotide-binding domain 
carries the “anchor” which tags Gα subunit to the membrane. 
The second domain of the Gα subunit, helical domain, is linked to the nucleotide-binding 
domain by means of flexible loops: switch I, switch II and switch III which form a 
hydrophobic core for nucleotide binding and undergo structural changes upon Gα activation. 
By binding to the receptor of the C-terminus, Gα undergoes a disorder-to-order 
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conformational change and therefore allosterically transduces the active receptor 
conformation into the rearrangement of the nucleotide-binding domain of the Gα subunit. 
Receptor-induced movement of the α5 helix leads to its dislocation from the β6 strand and the 
GDP release (Oldham et al. 2006; Van Eps et al. 2011). The mutations of the TCAT motif at 
the β6 strand of the Gα subunit, which is responsible for the Gα interaction with the guanine 
ring, enhance GDP release leading to constitutive G protein signalling (Thomas, Schmidt, and 
Neer 1993). The “empty” Gα subunit exists mostly in the “opened” conformation and has a 
distinct distance between helical and nucleotide binding domains (DeVree et al. 2016). Thus, 
G protein forms a very stable ternary complex (De Lean, Stadel, and Lefkowitz 1980) with 
the active receptor in absence of nucleotides bound to the Gα subunit. The stability of this 
complex is even more enhanced due to the ability of the G protein to allosterically increase 
the time of the agonist being bound to the ligand binding pocket of the receptors, for instance 
by a lid closure above the agonist molecule (DeVree et al. 2016).  
1.2.2 Gβγ subunits 
Gβ and Gγ subunits undergo specific assembly right after translation (Mende et al. 1995) 
and are delivered to the plasma membrane already in a complex (Mervine et al. 2006). They 
stay tightly bound to each other and function as a dimer (Dupré et al. 2008). 
Most combinations of the 5 Gβ- and 12 Gγ-subunits are functional. Some combinations 
seem to preferentially bind certain receptors or activate specific signalling pathways 
(McCudden et al. 2005). However, there is currently no evidence showing the preference of 
individual Gβγ-combinations towards certain Gα-subunits. In this work, only Gβ1γ2-subunits 
were investigated as the most characterized Gβγ combination (Dingus and Hildebrandt 2012). 
The Gβ subunit consists of seven β-blade motifs which form a narrow channel structure. At 
the bottom of this channel the Gα subunit binding site is positioned. Gγ subunits are rather 
small (7-10 kDa) and consist of two helices. The N-terminus of Gγ is tightly bound to the N-
terminus of the Gβ subunit forming a coiled-coil domain (Wall et al. 1995; Lambright et al. 
1996). Although, both Gα and Gγ subunits bind Gβ, no direct contacts between their helices 
were found. Recently resolved cryo-EM structures of M1-R-G11 and PTH1-R-Gs complexes 
suggest the possible interaction of Gβ residues and helix 8 of the receptor, but whether these 
contacts play a role in receptor or G protein functionality is not clear (Maeda et al. 2019b; 
Zhao et al. 2019). 
1.2.3 Selectivity of G proteins 
As previously mentioned, in comparison to GPCRs, G proteins have a lower variability, 
but the amount of combinations from different isoforms of 16 α, 5 β and 12 γ subunits is quite 
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large (Hillenbrand et al. 2015). In addition, activated Gα as well as Gβγ alone can interact 
with more than 25 different effectors (Siderovski and Willard 2005; Patel et al. 2014) (Table 
1), further enhancing the complexity of GPCR-induced signalling pathways. Although 
GPCRs exhibit a high degree of selectivity to a particular G protein class, it is a well-known 
phenomenon, that many GPCRs can activate several isoforms of G proteins from different 
families (Allgeier et al. 1994; Eason et al. 1992; Kilts et al. 2000; Hermans 2003; Herrlich et 
al. 1996). The number of potential combinations could be even more increased by the 
existence of different biased GPCR-agonists, which could preferentially activate certain G 
proteins better than others. Taken together, the complexity of GPCR-G protein coupling 
mechanisms gives rise to the question of how the receptor actually finds the right G protein.  
The specific receptor function to induce a particular cellular response is known to be 
determined by the type of the Gα subunit of the G protein (Kleuss et al. 1993; Kisselev and 
Gautamsb 1993; Strathmann and Gautam 1991; Yan, Kalyanaraman, and Gautam 1996; 
McIntire, MacCleery, and Garrison 2001). Due to direct interaction with the Gβ subunit 
which has been shown in G protein crystals (Wall et al. 1995; Lambright et al. 1996), Gα 
subunit determines the specificity of the downstream effectors of activated Gβγ.   
Experiments with mutated Gα and chimeras between different Gα subunits have shown 
the importance of the C-termini of Gα subunits for G-protein-receptor specificity (Conklin et 
al. 1993; Hamm et al. 1988). Also, based on sequencing results of different Gα subunits and 
computational evolutionary analysis, α5 of Gα was shown to play an important role in 
receptor- G protein coupling selectivity (Oldham and Hamm 2008; Slessareva et al. 2003) (T. 
Flock et al. 2015). Due to the high sequence homology and different G protein coupling 
specificity among family members, the mAChRs model is well suited to investigate receptor-
G protein selectivity. Recently resolved cryo-EM structures of M1-R- and M2-R-G protein 
complexes has also revealed the TM5 and TM6 as determinants of G protein selectivity of the 
muscarinic receptor family (Maeda et al. 2019b). Although, the structural data indicate the 
importance of different residue clusters for receptor-G protein specific interactions, the 
dynamics of GPCR-G protein is still not covered. In this work, I focus on the determinants of 
receptor-G protein selectivity.  
The results section include figures, text and calculated kinetic values from the publication 






1.3 Real-time measurements using Förster Resonance Energy Transfer (FRET) 
Förster resonance energy transfer microscopy is based on the physical phenomenon of 
radiationless energy transmission from donor to acceptor light-sensitive molecules. Due to its 
sensitivity to distance below the optical diffraction limited resolution (˂10 nm), FRET has 
been broadly used in biochemistry and molecular biology to study the conformational changes 
of the protein or protein-protein interaction dynamics (Figure 1). Intramolecular FRET is 
measured when both donor and acceptor fluorophores are incorporated in the same protein 
and the simultaneous alteration of acceptor over donor intensities reflect the conformational 
change of the protein (Figure 1B) (Stumpf and Hoffmann 2016). In my research project I 
mainly used intermolecular FRET which allows to determine the interaction of the protein 
labelled with donor and the protein labelled with acceptor fluorophore (Figure 1A). 
 
Figure 1. Inter- and intramolecular FRET scheme 
Intermolecular Förster resonance energy transfer (A) takes place when the binding of two 
labeled proteis donors (CFP) and acceptor (YFP) fluorophores come into close proximity 
(˂10 nm) and therefore the FRET efficiency increases. Intramolecular FRET (B) allows the 
detection of conformational alterations of the protein by measuring the change in the distances 
between the CFP and YFP fluorophores inserted into one molecule. Modified from Zhang et 
al. 2002. 
 
There are three most critical factors necessary in order for FRET to occur (Broussard et 
al. 2013b). As previously mentioned, FRET is a distance sensitive method. Resonance energy 
transfer between two fluorophores is observed when the donor and acceptor molecules come 
into proximity of 1 to 10 nm. The German physicist Theodor Förster developed FRET 
theoretical analysis and described the dependence of energy transfer efficiency (E1.1) on the 
inverse sixth-distance between donor and acceptor (Forster 1948).  






                                               (E1.1) 
Apart from the distance, a FRET pair of fluorophores should fulfil the requirement that 
the emission spectrum of the donor fluorophore must overlap with the excitation spectrum of 
the acceptor fluorophore (Figure 2A,B).   
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Since the resonance energy transfer is based on dipole-dipole interactions between 
fluorophores the donor and acceptor must be orientated parallel to achieve the optimal 
orientation factor (κ), ranging from 0 to 4. Even when the distance between FRET-pair 
fluorophores is less than 10 nm, the perpendicular position of the donor emission vector to the 
acceptor reduces FRET efficiency to zero. However, the degree of structural flexibility of 
fluorescent proteins used as FRET pairs in biological experiments allows the variety of 
orientations with averaged κ from 2 to 3 (Shrestha et al. 2015). 
 
 
Figure 2. Excitation and emission spectra of CFP and YFP as a FRET pair 
Normalized excitation and emission spectra of CFP and YFP are depicted. (A) The fields of 
CFP and YFP excitation as well as recorded emission ranges are depicted in accordance to the 
filters and detectors incorporated into the Nikon microscope (section 2.2.4.1). (B) The light 
magenta under the curve area represents the overlap of donor (CFP) emission spectra with 
acceptor (YFP) excitation spectra due to which resonance energy transfer between this pair of 
fluorophores can occur. The blue and pink striped areas depict the bleed through and false 
excitation regions (section 2.2.4.6) according to the used equipment (section 2.2.4.1). 
Modified from Broussard et al. 2013. 
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  1.3.1 Real-time detection of G-protein binding in permeabilized cells 
The stability of ternary complex (Agonist-Receptor-G protein) as well as the rate of G 
protein activation were determined by means of different biochemical approaches in vitro (De 
Lean, Stadel, and Lefkowitz 1980; Higashijima et al. 1987). In order to follow the minor 
changes in GPCR-G protein interaction dynamics in regular membrane environment, the 
ternary complex life-time was prolonged by cell permeabilization and depleting the 
nucleotides out of cell plasma membrane (Hommers et al. 2010). As development and 
validation of this method is part of my research project, the detailed description is given in 
section 3.1. 
      1.3.2 Real-time measurement of G-protein activity in intact cells 
The detection of G protein activation by means of FRET has been observed either as an 
increase or decrease of YFP/CFP intensity ratio, depending on the G protein subtype and 
insertion site of the fluorophores. The drop of FRET signal suggests the dissociation of Gα 
and Gβγ subunits (Hein and Bünemann 2009) or a conformational change of the G protein 
(Figure 3). However, the low initial YFP/CFP emission ratio and increase of the FRET signal 
upon agonist application can also indicate G protein activation due to the G protein subunits 
rearrangement without their complete dissociation form each other (Bünemann, Frank, and 
Lohse 2003). Usually, the direction of change in YFP/CFP emission ratio depends on Gα type 
and can vary within one G protein family: Gs and Gq activation reflects in FRET-signal 
decrease; Gi1 activation leads to increase in signal, whereas the drop in YFP/CFP emission 
ratio indicates Go protein activation. 
 
Figure 3. G-protein activation FRET assay scheme 
HEK293T cells are transfected as described in Table 2, placed on coverslips and constantly 
perfused with external buffer. (A) A close proximity of YFP and CFP tagged to Gα and Gβγ 
subunits of inactive G protein suggests a high initial FRET signal. Upon stimulation of GPCR 
with agonist G proteins are activated leading to the rearrangement of Gα and Gβγ subunits (B) 
and/or their subsequent dissociation from each other (C). In case of high initial FRET signal 




1.4 Aim of the study  
Recently, there were several research projects driven by the idea to investigate the 
mechanism of GPCR-G protein selectivity. The family of G protein coupled receptors 
(GPCRs) is the largest receptor family and each member detects specific ligands, which in 
turn activate selected members of one or more G protein families. Breakthroughs in GPCR 
crystallization gave detailed insight into the GPCR structures (Thal et al. 2016; Haga et al. 
2012), and GPCRs activation and interaction with downstream partners. However, the 
selectivity of receptor-G protein coupling and its underlying mechanisms remain unclear (Li 
et al. 2012; T. Flock et al. 2015).  
In accordance with the ternary complex model agonist, receptor and G protein remain 
stably coupled till GTP binds to the Gα subunit and immediately triggers G protein activation 
and its dissociation from the receptor (Dohlman 1991; De Lean, Stadel, and Lefkowitz 1980). 
We hypothesized that the mechanism underlying the coupling selectivity must be encoded in 
the receptor-G protein interaction. Therefore, I set out to measure the kinetics and affinity of 
the GPCR-G protein interaction in the absence of nucleotides in order to determine the 
affinity of the G proteins for the receptors in a quantitative manner. Due to the high 
concentration of nucleotides in the cytosol, the ternary complex has a very short lifetime 
(Oldham and Hamm 2008), therefore, previous methods to measure the GPCR-G protein 
affinity were mostly based on biochemical assays and required complicated protein 
purification steps (R. a Cerione et al. 1984; Eason et al. 1992; R. A. Cerione et al. 1985; 
Rubenstein, Linder, and Ross 1991). Thus, the advantage of a FRET-based approach is to 
quantify G protein affinity to the receptor in a regular plasma membrane environment. The 
aim of this research project was to assess the kinetics of the agonist driven interaction of 
GPCRs with representative G proteins from all 4 classes by means of FRET.   
  
2 Materials and Methods 
2.1 Materials 
2.1.1 Antibodies 
Anti-Gαq rabbit polyclonal (Santa Cruz Biotechnology, INC, Gαq(E-17):sc-393, dilution 
1:200 in 5% milk blocking buffer), anti-Gαo mouse monoclonal (Santa Cruz Biotechnology, 
INC, Gαo(E-1):sc-393874, dilution 1:200 in 5% milk blocking buffer) antibodies were used to 
detect the expression of respective Gα subunits of G proteins. Anti-Gβ polyclonal rabbit 
antibody (Santa Cruz Biotechnology, INC, Gβ(T-20):sc-378, dilution 1:500 in 5% milk 
blocking buffer) was applied for the detection of Gβ1γ2 expression. Anti-actin monoclonal 
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mouse antibody (MP Biomedicals, actin G9100, dilution 1:100000 in 5% milk blocking 
buffer) was used as a loading control after membrane stripping. 
2.1.2 Plasmids  
The plasmids used during my PhD project (Table 2) were already published and available 
in the lab. 
Table 2. Plasmids used in the study 




Bünemann et al., 
Proc.Natl.Acad.Sci.USA, 2003 
pcDNA3 
α2A-YFP mouse Krasel et al., J.Biol.Chem.2005 pcDNA3 
β2-AR human Krasel et al., J.Biol.Chem.2005 pcDNA3 
Gαq-wt mouse Hughes et al., J.Biol.Chem.2001 pcDNA3 
Gαo-wt rat Frank et al., J.Biol.Chem,2005 pcDNA3 
Gαi1-wt rat Wise et al., 1997 pcDNA3 
Gαi2-wt rat Frank et al., J.Biol.Chem,2005 pcDNA3 
Gαi3-wt rat Frank et al., J.Biol.Chem,2005 pcDNA3 
Gαs-wt rat Hein et al., J.Biol.Chem.2006 pcDNA3 
Gαq-YFP mouse Hughes et al., J.Biol.Chem.2001 pcDNA3 
Gαo- YFP rat Hommers et al., J.Biol.Chem.2005 pcDNA3 
Gαs-YFP human Hein et al., J. Biol. Chem. 2006 pcDNA3 
Gα13-YFP mouse Bodmann et al., FASEB J, 2017 pcDNA3 
Gαq-CFP human Hughes et al., J.Biol.Chem.2001 pcDNA3 
Gαo-CFP rat Frank et al., J.Biol.Chem,2005 pcDNA3 
Gβ1-wt human 




Bünemann et al., 
Proc.Natl.Acad.Sci.USA, 2003 
pcDNA3 
Gβ1-Cer human Frank et al., J.Biol.Chem,2005 pcDNA3 
CFP-Gγ2 bovine 




M1-R human  pcDNA3 
M2-R human Roseberry et al., Mol.Pharmacol.2001 pGES 
M3-R human 





TP-wt human Bodmann et al., FASEB J, 2017 pcDNA3 
TP-YFP human Bodmann et al., FASEB J, 2017 pcDNA3 
M3-R-YFP human Hoffmann et al., 2012 pcDNA3 









Cloned in AG Bünemann from mYFP 
construct  
pcDNA3 
pcDNA3  Invitrogen pcDNA3 
 
2.1.3 Chemicals 
If not indicated in the table, the substance was purchased from Sigma-Aldrich 
(Steinheim, Germany). 
Table 3. Chemicals, used in the research project 
Reagent Supplier 
Dulbecco’s modified Eagle’s medium (DMEM) high glucose Biochrom 
Fetal calf serum (FCS) Biochrom 





Acetic acid Carl Roth 
Acrylamide/Bisacrylamide Carl Roth 
Agar AppliChem 
Ampicillin AppliChem 
APS Sigma Aldrich 
ß-merapthoethanol Sigma Aldrich 
BSA (delipidated) Sigma Aldrich 
Bradford reagent  Sigma Aldrich 
Dimethyl sulfoxide Sigma Aldrich 
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EDTA Sigma Aldrich 
Ethanol Carl Roth 
G-418 Capricorn 
HEPES Sigma Aldrich 
Immersion Oil Immersol Zeiss 
Isopropanol Carl Roth 
LB-broth AppliChem 
L-Glutamine AppliChem 
Milk powder Carl Roth 
Poly-L-lysine Hydrobromide (PLL) Sigma Aldrich 
PAGE-size standards Thermo Scientific 
Tris Sigma Aldrich 
TEMED Carl Roth 
Tween (20) Sigma-Aldrich 
U-46619 Cayman Chemical 
Acethylcholine Sigma Aldrich 
Carbachol Sigma Aldrich 
Petussis toxin Sigma-Aldrich 
BQCA Cayman Chemical 





H ] American Radiolabeled 
Chemicals 









2.1.4 Buffers  
All the buffers were prepared in the lab apart from PBS (purchased from Capricorn 
Scientific GmbH, Ebsdorfergrund, Germany). High glucose DMEM (purchased from 
Biochem) was only supplied with additional substances depending on cell line. Ultra-filtered 
water (Ultra Clear UV plus, Reinstwassersystem; SG Wasseraufbereitung, Barsbüttel, 
Germany) was used for all water-based buffers.  
Unless indicated differently, the working solutions for the assays were used in a single-
strength concentration. 
 
Dulbecco’s Modified Eagle Medium (DMEM) supplements list 
Compund Concentration 
Fetal calf serum (FCS) 10,00% 
L-Glutamine 2 mM 
Penicillin 100 U/ml 
Streptomycin  100 µg/ml 




NaCl 137 mM 
KCl 5.4 mM 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid ) 10 mM 
CaCl2 2 mM 








-aspartate 100 mM 
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KCl 30 mM 
HEPES  10 mM 
EGTA (ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic 
acid) 
5 mM 
MgCl2 1 mM 
NaCl 10 mM 
pH 7.35 
-filter sterile 
-store at 4  C 
 
LB-broth (bacterial medium) 
Compound Concentration 
Peptone 1.0 % 
Yeast extract 0.5 % 
NaCl 1 % 
Water  
-autoclave 




Agar 1.5 %  
LB-broth   
-autoclave 
-store at RT 
 
TSB (transformation and storage buffer for chemical competent E.coli) 
Compound Concentration 
PEG 3000 10 % 
DMSO 5 % 
MgSO4 or MgCl2  20 mM 
LB-broth   
-filter sterile 




5 x KCM buffer 
Compound Concentration 
KCl 500 mM 
CaCl2 150 mM 
MgCl2  250 mM 
Sterile water  




HEPES 10 mM 
EDTA 0.05 %  
NaCl 0.9 % 
Water pH 7.4 




HEPES 20 mM 
MgCl2 1 mM 
Water pH 7.4 
-store at 4  C 
 
Lysis buffer (Western-Blot) 
Compound Concentration 
Tris 20 mM 
EDTA 2 mM 
Proteinase inhibitors mix 
(Complete ULTRA tablets mini, EDTA free, Roche)  
1 tablet / 10 ml buffer 
Water   





5 x Sample buffer (Western-Blot) 
Compound Concentration 
Glycerine 50 % (m/v) 
Tris 312.5 mM 
SDS  10 % (m/v) 
β-mercaptoethanol 25 % (m/v) 
Bromephenol blue 0.1 % (m/v) 
Water  
- store aliquoted at 4  C 
 
10 x Running buffer for SDS-PAGE (Western-Blot) 
Compound Concentration 
Glycerine 14,4 % (m/v) 
Tris (base) 2.5 M 
SDS  10 % (m/v) 
Water  
- store at RT 
 
10 x TBS  
Compound Concentration 
NaCl  5 M 
Tris (base) 2 mM 
Water  
pH 7.5  
- store at RT 
 
1 x TBST  
Compound Concentration 
Tween 20  0.05 % (v/v) 
TBS  





1 x Transfer buffer (Western Blot) 
Compound Concentration 
Tris (base)  25 mM 
Glycerine 1.4 % 
Methanol 20 % 
Water  
pH 8.3  
- store at RT 
 




 5 % (m/v) 
TBST  
- to be fresh prepared 
 
Stripping buffer (Western Blot) 
Compound Concentration 
Glycerine 1.5 (m/v) 
SDS 0.1 % (m/v) 
Tween 20 1 % (v/v) 
Water  
-store at RT 
 
PFA (Paraformaldehyde, Immunofluorescence) 
Compound Concentration 
PFA  4 % 
PBS  
- PFA is soluble in PBS at 70  C 





Blocking solution (Immunofluorescence) 
Compound Concentration 
FCS 5 % (v/v) 
Triton X 0.2 % (v/v) 
SDS   
- to be fresh prepared 
 
2.1.5 Software 
-Plasmid sequences, alignments: 
      ApE- A plasmid Editor  
-Data analysis and statistics: 
Microsoft Excel 2013 (Microsoft, Redmond, WA) 
GraphPad Prism 5 (San Diego, CA, USA) 
OriginLabs OriginPro 8.5(Northampton, MA, USA) 
OriginPro 9.1 (Northampton, MA, USA) 
Nest-o-patch (Friedrich-Alexander-Universität, Erlangen-Nürnberg, Germany) 
-Image analysis and its modification: 
      ImageJ 1.46r (National Institutes of Health, Maryland, USA) 
      LAS AF light (Leica Microsystems, Germany) 
-Figures modifications and vector graphics: 
      CorelDraw X4 
2.1.6 Bacteria strains and cell lines 
HEK293T (Human Embryonic Kidney 293T) used for all FRET-experiments, radioligand 
binding and biochemical assays was a kind gift from Martin Lohse. HEK293 cell line was 
used in order to create stable Flag-M3-R expression clones. 
2.1.7 Consumable material 
Table 4. Materials used in the studies 
Consumables Supplier Supplier 
Centrifuge tubes (15 ml, 50 ml) Greiner Bio-One 
Cover slips, 25 mm VWR 
Cryogenic vessels Hartenstein 
Dishes for cell culture(150 mm, 100 mm,60 mm, 96-well plates, 6-well) Sarstedt 
Pasteur pipettes Hartenstein 
Petri dishes Hartenstein 
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Pipette tips 2μl, 20μl-200μl, 1000 μl Sarstedt 
PVDF membrane Roche 
Reaction vessels (1.5 ml) Sarstedt 
Syringes for single use Neolab 
Stripps, 12-well Greiner Bio-One 
Whatman® paper VWR 
 
2.2 Methods 
 The recipes of the buffers, used in the following protocols, are given in the section 2.1.4. 
2.2.1 Molecular biology 
2.2.1.1 Generation of chemical competent E.coli  
Competent E.coli were prepared according to a modified protocol by Chung et al. 
(Chung, Niemela, and Miller 1989). The E.coli DH5α strain was plated on an LB-agar plate 
and incubated overnight at 37 °C. A single colony was picked and precultured overnight in 10 
ml LB-broth on the shaker at 37 °C. Five to 10 ml of bacteria preculture was added to the 250 
LB-broth final volume and shaken at 37  C until OD600=0.4-0.6. The bacteria were harvested 
by 10 minutes centrifugation at 5000 rpm 4  C. The pellet was resuspended in 25 ml of ice-
cold TSB buffer. The suspension was incubated on ice for 2 hours, aliquoted and frozen in 
liquid nitrogen. Aliquots stored at -80 °C. 
2.2.1.2 Transformation of chemical competent E.coli 
Bacteria (chemical competent E.coli) should be thawed on ice.  
Compound Concentration 
5x KCM-buffer  20 μL  
Autoclaved water  80 μL  
DNA  0.5 μg  
Competent bacteria 100 μL  
The mixture was incubated on ice for 10 minutes, then 20 minutes at RT. One ml LB-
broth (autoclaved) was added to the mixture and bacteria were incubated for 50 minutes at 
37°C at 850 rpm (ThermoMix). Sixty-80 µl of the final mixture was plated on agar (with the 





2.2.1.3 Plasmid preparation 
Plasmids were purified from 100 mL bacteria suspension grown overnight with an 
appropriate amount of antibiotic using Qiagen Plasmid Midi Kit according to the 
manufacturer’s protocol. 
 2.2.2 Biochemical approaches 
 2.2.2.1 Western-Blotting 
Western blots were done on transiently transfected HEK293T cells. Cells were split on 10 
cm dishes and transfected with double amount of Plasmid mixture “G protein binding 
experiments” (Table 6 section 1) by Effectene Reagent Kit (QUAGEN) as described in 
section cell culture and transfection and depicted in Figure 11. The transfection was stopped 
after 18 hours by changing medium. Twenty-four hours later, transfected cells were washed 
once with PBS buffer, resuspended in 1 ml Lysis buffer, scratched from the plate and 
transferred into a 1.5 ml tube. The cell suspension was briefly dipped in liquid nitrogen and 
stored at -80°C. The whole-cell lysates were thawed on ice homogenised by 30 second pulse 
by Ultra-Turrax (Model IKA T10 basic). The protein amount was determined by with BCA 
Reagent kit.  
The 10%  SDS 1.5 mm thick PAGE gel was poured according to the following protocol: 
Separating Gel (1 Gel-10 ml) 
H2O   4 ml 
30% Acrylamid 3.3 ml 
1.5 M Tris (pH=8.8) 2.5 ml 
10% SDS 0.1 ml 
10% APS 0.1 ml 
TEMED 4 µl 
The edge of separating gel was smoothed with Isopropanol, which was depleted right 
after polymerisation and before pouring the concentration gel on top. 
Concentrating Gel (1 Gel-5 ml) 
H2O   3.4 ml 
30% Acrylamide 0.83 ml 
0.5 M Tris (pH=6.8) 0.63 ml 
10% SDS 0.05 ml 
10% APS 0.05 ml 
TEMED 5 µl 
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Each probe was diluted until 100 µg of protein in 40 µl of Lysis buffer with addition of 5 
µl 5x sample buffer. Samples were vortexed, shortly centrifuged and denaturized by heating 
up to 95 °C for 15 minutes at 650 rpm (Thermomix). The samples were centrifuged again and 
loaded into SDS-Page pockets. In at least 1 pocket pro gel, 10 µl of Page Ruler was added. 
Electrophoresis was performed for 25 min at 60 V in concentrating gel and for 1-2 hours at 
100-120 V in separating gel. The PVDF membrane (Roche) was activated in MetOH and 
stored in transfer buffer till the “sandwich” of membrane, gel, and sponges was built. The 
protein transfer to the PVDF membrane was performed by means of wet blotting 2 hours at 
200 mA and overnight (about 18 hours) at 20 mA at 4 °C with a constant mix. The membrane 
was blocked by 1-hour incubation with 5% milk in TBST (further “milk”) at RT. The primary 
antibody was diluted in “milk” and incubated with the membrane overnight at 4 °C following 
1-hour incubation at RT. The membrane was washed three times each 15 minutes with TBST 
buffer (Table 5). The secondary HRP-labelled antibody diluted in “milk” was applied on the 
membrane for 1-hour at RT with no light access (Table 5). The membrane was again washed 
three times 15 minutes each with TBST buffer. In order to detect bioluminescence with 
Chemidoc (BioRad, LiveAcquire: 300 sec, 10 images), the membrane was incubated with 
ECL Kits HRP detecting solution (3 ml of each solution per 1 membrane) for 10 minutes on 
the shaker with no light access. TIFF-images were quantified by means of ImageJ (1.46r; 
http://imagej.nih.gov/ij/). 
The following steps were only performed if another antibody was used on the same 
membrane (e.g. protein loading or expression control). The membrane was stripped, washed 
with water (5 minutes on the shaker) and incubated with stripping buffer for 15 minutes. The 
stripping buffer was further depleted by washing twice for 5 minutes with PBS followed by 
the same process this time with TBST. The membrane was blocked by “milk” and primary 
and secondary antibodies were applied as described previously for the first run of protein 
detection. 
Table 5. Antibodies used in the study 
Target Application Clonality Item  Dilution Species Supplier 
Gαq primary polyclonal E-17:sc-393 1:200 rabbit Santa Cruz 
Biotech. 
Gαo  primary monoclonal E-1:sc-
393874 
1:200 mouse Santa Cruz 
Biotech. 




Actin primary monoclonal G9100 1:100000  mouse MP 
Biomedicals 
Mouse secondary  7076 1:3500 horse Cell Signalling 
Rabbit secondary  7074/P2 1:3500 goat Cell Signalling 
 
2.2.2.2 Immunofluorescence 
The immunofluorescence analysis was performed for the control of M3-R expression by 
the stable HEK293 cell line. The plasmid encoding M3-R with Flag tag at the N-terminus was 
transfected in HEK293 cells by Effectene Quagen Kit according to the manufacturer’s 
protocol. The first generation clone selection was performed after 2 weeks of culturing 
transfected cells in DMEM 10% FCS supplied with 1.0 µg/ml G418. Second generation clone 
selection was done after 2 weeks culturing of the clone 1 in DMEM 10 % FCS supplied with 
0.5 µg/ml G418. For the Flag-tag immunostaining, the depicted clone was cultured on glass 
coverslips coated with Poly-L-lysine. Cells were washed once with PBS and if needed 
followed by 4% PFA (paraformaldehyde) incubation (to control the amount of unfolded or 
degraded M3-R-Flag in the cytosol) at RT for 15 minutes. PFA was properly washed with 
PBS and cells were incubated for 1 hour with blocking solution. First antibody (Harpine Anti-
Flag goat, 1:200 in blocking solution) was applied on the cells for 2 hours. Second antibody 
(anti-goat 1:2000, blocking solution) was applied for 1 hour and protected from light. After 
washing steps with PBS, cells were fixed on coverslips by Vectraschield mounting medium at 
the RT with no light access for 1 hour. The fixed immunostained cells were stored in a light-
protective case at 4°C or directly analysed under epifluorescence Leica microscope (Leica 
DMI 6000B with a Leica DFC360 FX camera). Confocal pictures were acquired with an 
excitation wavelength of 405 nm (laser diode) and 514 nm (Ar-laser).  
 2.2.2.3 Radioligand binding assay 
The expression levels of wild type M3-Rs were determined in the membranes as 
described in Cembala et al. (Cembala et al. 1998). HEK293T cells were transiently 
transfected with M3-wt, YFP labelled Gα of interest, Gβ1-wt, and CFP labelled Gγ2 subunit. 
Cells were harvested 2 days after transfection into homogenization buffer and homogenized 
using Ultra-Turrax. In order to isolate membranes, the homogenized cells were centrifuged 
for 15 min at 10 000 g at 4°C and resuspended in assay buffer (20 mM HEPES, 1 mM MgCl2 
at pH 7.4). Protein concentration was determined by Pierce BCA protein kit (Thermo 
Scientific, IL, USA) according to the manufacturer’s instructions. The incubation of 
membranes with [
3
H]-scopolamine methyl chloride (specific activity: 80 Ci/mmol, American 
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Radiolabeled Chemicals, MO, USA) in a total volume of 1 ml assay buffer was performed at 
37 °C for 1 h. The separation of free and bound radioligand was done by filtration through 
glass fibre filters (Whatman®, 25 mm). The counting procedure was done after extraction of 
radioactivity from the glass fibre filters at least 12 h in 4 ml scintillation fluid (Ultima Gold, 
Perkin Elmer, USA) using Liquid scintillation analyser (1600-TR, Tri-Carb, Pakard, Canberra 
Company). Non-specific binding was determined in presence of 10 µM atropine. 
2.2.3 Cell culture and transfection 
Experiments were performed in HEK (human embryonic kidney) 293T cells (a kind gift 
from M. Lohse, Würzburg, Germany). Cells were maintained in high glucose culturing 
medium (4.5 g/L) Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10 % 
FCS, 2 mM L-glutamine, 100 U/mL penicillin and 0.1 mg/mL streptomycin at 37°C, 5% CO2. 
Cells were passaged every 2-3 days in 10 cm Petri dishes. Cell culturing in 6 cm dishes was 
performed for further transfection with DNA of interest. When cell density in the plate was 
estimated from 30-70%, cells were transfected with a mixture of plasmids not exceeding 3.2 
µg of total DNA per 3.5 ml medium (Table 6. Plasmid mixtures for HEK293T cells 
transfection) using Effectene Transfection Reagent according to the manufacturer’s 
instructions (Qiagen, Hilden, Germany). Transfection procedure lasted normally 16-20 hours 
and was stopped by changing medium on 6 cm plates. Eighteen hours before FRET-
experiments, transfected cells were transferred from 6 cm plates to 6-well plates 25 mm 
coverslips (cover glasses were preincubated 40 min with poly-L-lysine for a better cell 
adhesion). Fluorescent microscopy experiments were performed at room temperature. 
Table 6. Plasmid mixtures for HEK293T cells transfection 
1. G-protein binding experiments (permeabilized cells) 
Plasmid µg 
Receptor-YFP 0.5 
Gα-wt / pcDNA3 (no Gα) 1.5 
Gβ1-wt 0.5 
CFP-Gγ2 0.25 
2. Gα-subunit direct binding to the receptor experiments (intact cells) 
Plasmid µg 
Receptor-YFP 0.5 












2.2.4 Fluorescence microscopy 
2.2.4.1 FRET-microscopy equipment 
The FRET measurements were performed on single cells selected for membrane staining 
of YFP and CFP fluorescence. The round shape of cells was taken as an indicator of proper 
permeabilization (Figure 6B vs Figure 6E). Dual-emission imaging of YFP and CFP of a 
single cell (or its membrane) was performed by inverted fluorescence microscope (Eclipse Ti; 
Nikon, Düsseldorf, Germany) supplemented with a light-emitting diode (LED) excitation 
system (pE-2; CoolLED, Andover, UK) containing LEDs emitting light at 425 nm for CFP 
and 500 nm for YFP excitation. The filters ET 430/24x (CFP excitation), ET 500/20x (YFP 
excitation), T455LP (combined fluorescence of CFP and YFP) or CFP/YFP-beam splitter 
supplied with CFP/YFP emission filter (Cat.No. 59017bs and 59017m) purchased in Chroma 
were introduced into the Nikon microscope. In order to simultaneously record CFP and YFP 
fluorescence using a fast CCD camera (Evolve512, Roper Scientific), z488/800-1064rpc 
(separating emission of CFP and YFP), ET 480/40 (CFP emission only) and HC 534/20 (YFP 
emission only) were set in an Optosplit II (Cairn Research). Microscope, camera and DG-4 
were controlled using NIS-Elements AR (Laboratory Imaging). Synchronization of camera 
and lamp was driven by a Nikon software implicated triggering-box. During FRET 
measurements cells were excited with 430 nm light (CFP excitation wave length) and the CFP 
and YFP emissions were recorded simultaneously. Depending on the fluorescence intensity, 
the illumination time was set to 30-90 ms at an interval of 500 ms. The intensity of both LEDs 
was set to 2%. Image recording frequency was set to 2 Hz in correlation to the exposure time 
(60-100 ms). Fluorescence intensities were acquired using imaging software NIS-Elements 
advanced research (Nikon Corporation, Melville, NY, USA). FRET was followed over time 
by plotting the ratio of YFP intensity divided by CFP intensity upon excitation of CFP at 425 
nm LED. All fluorescence data were corrected for background fluorescence, false YFP 
excitation, CFP spillover and photobleaching.  
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2.2.4.2 FRET-microscopy in single living intact or permeabilized cells 
The single cell FRET measurements were done at RT 48 hours after transfection. 
Coverslips with transiently transfected HEK293T cells were set in a microscope chamber and 
washed once with External buffer to reduce the amount of auto fluorescent proteins coming 
from FCS supplemented DMEM. FRET measurements of G protein activation were 
performed in external buffer. During the experiment intact cells were continuously superfused 
with external buffer or buffer containing ligands in different concentrations using a fast-
switching 8 channel valve-controlled pressurised perfusion system with solenoid valves (Ala-
VC³-8SP, Ala Scientific Instruments). FRET measurements on G protein-receptor binding 
under nucleotide-depleted conditions were performed in internal buffer (high potassium 
buffer) on single permeabilized cells. The cell permeabilization procedure was done directly 
on a coverslip directly before the measurement by brief (2 minutes) cell exposure to 0.05 % 
Saponin. The nucleotides and the rest of Saponin were depleted by washing 5 times with 
internal buffer (Hommers et al. 2010). 
 2.2.4.3 Multiple-Cell FRET imaging 
The efficiency of G protein activation by the receptor of interest was determined by 
means of multiple-cell FRET assay in intact cells transiently transfected as previously 
described in Frank et al., 2005. Fluorescence was excited with violet light of 435 nm with 
short light pulses of 10-40 ms followed by darkness for the same time interval (10–40 ms) to 
minimize photobleaching. Each of the 12 channels was equipped with an independent 
excitation/detection unit. Excitation light passed band-pass filters of 435 ± 20 nm. After 
passage using a dichroic mirror (511 nm), the fluorescent light passed band-pass filters of 483 
± 16 nm and 540 ± 25 nm for the detection of blue (CFP) and yellow light (YFP), 
respectively. Emitted light was detected by low noise silicone photodiodes (OSD15-5T, 
Centronic, Croydon, UK). After a >100000-fold amplification of the photocurrent with a two-
stage amplifier (operational amplifiers OPA111 and OPA121, Texas Instruments, USA) 
fluorescent signals were digitized and sent (FTDI-USB, 921600 baud) to a personal computer 
(core2duo, 3 GHz or faster). Computer software was programmed to allow the continuous 
recording of fluorescence data, for instantaneous display on a conventional screen, and to file 
data for subsequent data analysis. As all electronic components were chosen to be smaller 
than 9 mm (i.e. 96-well format), each of the 12 channels could be equipped with independent 
excitation/detection units, so that fluorescence data could be continuously monitored at a high 
data sampling rate (~100 Hz).Transfected HEK293T cells were cultivated in 12-well strips 
(TC, 96-well format, Greiner Bio-One) were washed with and maintained in external buffer A 
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(137 mM NaCl, 5.4 mM KCl, 1.0 mM MgCl2, 2.0 mM CaCl2, 10 mM HEPES, 2% Brilliant 
Black) at 32.5 °C. The final volume was 275 µl per well. Injections of test compounds 
(agonists and antagonists) were made with a volume of 22 µl added gradually with gentle up 
and down movements of the 12-channel injecting unit equipped with 50 mm needles (1.2 mm 
diameter), resulting in a 13.5-fold dilution of stock solutions. Alternatively, cells were 
stimulated with an overflow apparatus allowing fast (< 3 sec) change of the standard buffer to 
induce receptor stimulation.  
 2.2.4.4 Quantification of absolute and relative expression levels by means of 
fluorescence. 
The stoichiometry of the relative expression level of YFP and CFP was calibrated to the 
reference construct. HEK293T cells transiently transfected with YFP-β2-AR-CFP plasmid 
(Dorsch et al., 2009), where fluorophore fused to tags ß2-R with 1:1 ratio. YFP and CFP 
selective intensities were measured individually and corrected for the background. FCFP was 
divided by FYFP to calculate the calibration factor. To calculate the individual expression ratio, 
the FCFP/FYFP-ratio of the Gγ/M3-R-FRET cells was measured similarly and was divided by 
the calibration factor to estimate the amount of CFP-Gγ2 overexpression over M3-R-YFP. 
2.2.4.5 Confocal microscopy 
Confocal microscope Leica DMI 6000B supplied with Leica DFC360 FX camera was 
used to acquire images of immunofluorescent labelled cells stably expressing Flag-tagged M3-
R as well as for high quality imaging of localization of fluorescent receptors and G proteins in 
transiently transfected permeabilized cells.  
2.2.4.6 Correction factors 
As mentioned in the methods, apart from the background fluorescence raw FRET data 
were corrected for several factors caused by crosstalk between chosen FRET-pair 
fluorophores as well as settled filters and lenses.  
Due to the overlap of donor emission and acceptor excitation, there is a varied degree of 
contamination of acceptor emission channel with donor emission fluorescence, called “bleed 
through” or “spillover” (Figure 2B) (Ishikawa-Ankerhold, Ankerhold, and Drummen 2012). 
The contribution of CFP in the YFP detected emission (F534 channel) was calculated as “bleed 
through” correction factor by dividing emission from F534 by F488 derived from HEK293T 
cells expressing only membrane associated CFP. The “bleed through” correction factor is 
assumed to be a systematic error which depends on the filters and detection elements used 
and, therefore, has a constant value which can only differ over a long period of time due to the 
amortisation of the filters. At the time of the experiments performed in this research project, 
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the contribution of CFP fluorescence into YFP detected emission accounted for was 0.3886 (~ 
40%). 
Furthermore, the crosstalk of fluorophores also includes the direct excitation of the 
acceptor at the donor absorption wavelength (Shrestha et al. 2015), called “false excitation”. 
In order to measure the correction factor for false YFP excitation, HEK293T cells were 
transfected with YFP-containing plasmid alone and the emission in the F534 channel was 
recorded for excitation at 430 nm. As in the case of “bleed through” correction factor, the 
“false excitation” value is constant and was compiled as 0.0452 (~ 4%).  
Since the recording of both donor and acceptor fluorescent intensities was performed 
under consecutive excitation of the donor only, the total YFP expression in the cell was 
calculated as YFP emission under 500 nm excitation wavelength derived from the additional 
20 seconds measurement, which took part after the main experiment.  
Thus, the final sensitized YFP emission (    
  ) can be calculated (Youvan et al. 1997) by 
following equation: 
    
      
                    
                                   (E2.1)          
where     
  and       are YFP and CFP emission intensities respectively measured during 
actual experiment,     
  is the intensity of YFP measured in F534 channel under direct acceptor 
excitation, 0.4 and 0.04 are “spillover” and “false excitation” correction factors calculated for 
Nikon setup respectively. 
The final corrected FRET signal was calculated as a ratio of corrected YFP (    
  ) over 
measured CFP      intensities. 
One more parameter which has been corrected for most of the experiments described in 
this work is photobleaching. Due to continuous or frequent illumination the fluorophore is 
caged in a dark triple excited state and therefore unable to repetitively enter 
excitation/emission cycles (Ishikawa-Ankerhold, Ankerhold, and Drummen 2012). Thus the 
emitted light fades over time which lead to the drift in FRET signal. The photobleaching 
correction was performed by fitting the exponential function to the base line of each 
individual FRET experiment recording in Origin 8.5. 
 
2.2.5 Data analysis and statistics 
In this section I would like to briefly discuss the basic concepts of chemical reaction 
kinetics. The rate of chemical reaction (w) is one of the most important quantitative kinetic 
parameters of biochemical process and is defined as the alteration of the amount of substance 
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that reacts (n) or the amount of reaction product (n) at a particular time point at a particular 
volume: 






                                                                                   (E3.1) 
If we assume my experiments are constricted to a single living cell, the volume of the 
system where the reaction takes place is constant: 






)    
  
  
                                                                   (E3.2) 
The dependence of the chemical process rate (w) from the concentration of different 
components of the reacting system (C) is described by the following equation: 
                                                                                      (E3.3) 
Depending on the reaction, function f can be more complex. Empirically, it has been 
shown that the rate of chemical reaction is proportional to the reagent concentration (C) raised 
to the nth power: 
     
 
  
   
  
    
    
                                                    (E3.4) 
where vi is the stoichiometry coefficient of the reagent, t is a time point, k is a rate 
constant. 
Since in my research project I focus on the interaction of two proteins which under the 
application of the ligand form a stable complex, the general equation for this biochemical 
process looks like: 
L + R + G ↔ Z                                                                             (E3.5) 
Where L is ligand, R-receptor, G - G protein and Z is a ternary complex. Under 
nucleotide-depleted conditions the GPCR-G protein binding is a limiting factor for the rate of 
the reaction, the influence of agonist association and dissociation rate in the E3.5 is further 
neglected. All experiments were done at RT, therefore, no extra calculations were required for 
comparison of different kinetics parameters. 
If we define z as total amount of ternary complexes Z which can be formed according to 
the amount of the receptors expressed (R), and b is a number of receptors bound to G proteins 
by the time point t, E3.4 can be presented as: 
           
  
  
                                                                    (E3.6) 
      
  
   
                                                                                   (E3.7) 
Where (z-b) is the amount of the receptors not bound to G proteins at the time t.  
By integrating from 0 to b and 0 to t, the equation E3.7 is transformed to: 
∫
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                                                                                      (E3.11) 
The time when half of the receptors are occupied by the G proteins is defined as half-time 
of the reaction (τ1/2). It means, that the number of ternary complexes formed by the half-time 
of the GPCR-G protein binding reaction is defined as Z/2. Therefore: 
     
   
 
 
     
 
                                                                        (E3.12) 
Since this relation is simple and can be depicted as in Figure 4, we can conclude that the 
half-life of a first-order reaction is a constant. 
 
Figure 4. Half times for the example of the first-order reaction 
Since τ1/2 depends on the initial concentrations of the interacting partners and their individual 
properties (E3.6, E3.7), the given numbers are not the case for all biochemical reactions. 
 
The potentiation of E3.12 leads to the exponential dependence of the amount of free and 
G-protein occupied receptors on time of the reaction: 
                                                                               (E3.13) 
The reactions which kinetics can be described by equations E3.12 and E3.13 are defined 
as first-order reactions and if plotted as logarithmic concentration over time represent a 
straight line (Figure 5). 




Figure 5. Comparison of the decay of first-order reactions 
The schemes depict the logarithmic (A) and linear (B) dependence of biochemical agent 
concentration over time. The presented tangents to mono-(C) and two-exponential (D) curves 
are supplied with the equations used to calculate rate constants. 
 
The rates of association and dissociation of GPCR and G protein were calculated by 
fitting the mono- (Figure 5C) or two-phase (Figure 5D) exponential functions to the curves 
derived from FRET experiments as depicted in Figure 19C. 
Individual traces are shown as either absolute or relative YFP/CFP emission ratio 
changes. Absolute changes in YFP/CFP emission ratio were calculated as a difference in 
average values of the last 10 seconds before or after an event. The relative change of 
FYFP/FCFP was calculated by normalization to the maximum peak after application of 
saturating agonist concentration relative to the G protein-free state, determined by application 
of GTPγS. As a measure of the affinity of G protein-receptor complex, dissociation kinetics of 
the complex were measured under nucleotide-free conditions in response to agonist 
withdrawal. Resulting data of the offset kinetics (decrease in FRET) were fitted by a 
monoexponential function.  
 
3. Results 
3.1 Imaging ternary complex by means of FRET 
In order to investigate the affinity of the receptor-G protein interaction, the dynamics of 
G proteins binding to activated GPCRs and their subsequent dissociation was analysed by 
FRET microscopy under conditions of GTP-depletion. HEK293T (Human Embryonic 
Kidney) cells expressing M3-R-YFP, Gαq, Gβ1 subunits, and CFP-Gγ2 were subjected to 
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single cell FRET imaging (Figure 6A,B) similar to the process described previously (Milde, et 
al., 2013). In intact non-GTP-depleted cells, we observed a small and rapidly reversible 
increase in FRET as also shown previously for other receptors (Figure 6C) (Hein, Bünemann, 
2005). We then permeabilized cells by a 2 minute exposure to 0.05% saponin (Figure 6D,E,F) 
in order to deplete membranes from nucleotides, thus allowing the development of relatively 
stable agonist-receptor-G protein complexes (Hommers et al. 2010). The amplitude of the 
FRET signals in permeabilized cells was substantially higher, indicating a largely increased 
occupancy of receptors with G proteins (Figure 6F). Most importantly, after withdrawal of the 
agonist we observed much slower dissociation kinetics of Gq from M3-R in absence of 
nucleotides (Figure 6C vs. F) which reflects the high intrinsic affinity of G proteins to active 
receptors under conditions of nucleotide-depletion. The rapid drop of the FRET signal in 
response to GTPγS indicates nucleotide-dependent fast dissociation of the remaining receptor-
G protein complexes (Figure 6F).  
 
Figure 6. Dynamics of G protein-M3-R interaction in absence of nucleotides 
CFP-labelled Gq protein binding to the YFP-labelled M3-R was measured by means of FRET 
in intact (A, B, C) and in permeabilized (D, E, F) cells as schematically illustrated in (A, D). 
Confocal microscopy images of CFP fluorescence in HEK293T cells transfected with M3-R 
C-terminally labelled with YFP, Gαq-wt, Gβ1-wt, and Gγ2 N-terminally labelled with CFP 
were derived prior (B) and after membrane permeabilization by brief incubation with Saponin 
(E).  FRET measurements were performed on single intact and permeabilized cells excited at 
435 nm and exposed to agonist or GTPγS as indicated (C and F respectively). The YFP/CFP 
emission ratio derived from a single cell was calculated and plotted over time (E, F). Upon 




3.2 Selectivity of G protein binding to mAChRs 
3.2.1 Quantification of G protein intrinsic affinity to M3-R 
Based on reports that M3-Rs may also couple to Gi/o and even Gs proteins (Jones, et al., 
1991), we wanted to quantify the selectivity of M3-Rs binding to 4 different classes of G 
proteins under conditions of nucleotide depletion. Therefore, we compared the agonist (10 
µM acetylcholine (ACh)) evoked FRET signal between fluorescent M3-R and fluorescent Gβγ 
subunits proteins when Gαq, Gαo, Gαs, Gα13 or pcDNA3 instead of Gα was transfected (Figure 
7A). As depicted in Figure 7A, there were no significant differences in the small agonist-
evoked FRET signals in cells transfected with Gαs or Gα13 compared with those that were 
transfected with empty vector instead of cDNA encoding for Gα subunits, indicating no 
detectable interactions.  
 
Figure 7. Quantification of G protein-receptor selectivity 
Interaction of Go, Gq, Gs or G13 proteins with M3-R induced by agonist application was 
measured by means of FRET in permeabilized cells similar as described in Figure 6F. (A) The 
graph depicts average FRET signals derived from cells, transiently transfected with YFP 
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labeled M3-R, CFP-labeled Gγ2 subunit and indicated in the legend Gα subunit. YFP/CFP 
emission ratios were normalized to minimum receptor occupancy state induced by GTPγS 
application. Compared to the increase in FRET signal under ACh application when no Gα but 
the empty vector pcDNA3 was transfected no specific binding of either Gs or G13 protein 
binding to M3-R was observed. (B) Quantification of dissociation constants (koff, s
-1
) for Go 
and Gq proteins from M3-R (n=14; n=30 respectively) are illustrated. (C) Hyperbolic function 
was fitted to the measured values of on-rate kinetics (kobs, s
-1
) of Gq protein binding to M3-R 
induced by different CCh concentrations under GTP-depleted conditions (D) Comparison of 
kon values of M3-R-Gq association kinetics (light grey) obtained from fitted hyperbolic 
function using equation E4.2 and steady-state experiments ( 𝑜 
  of Gq (black)) and Go data 
(magenta), calculated using equation E4.3. All data are plotted as mean ± SEM for each 
condition. N of each experiment is shown in brackets if not indicated in the legend.  
 
 
The comparison of Gq and Go dissociation rate from M3-R during the withdrawal of 
agonist in absence of nucleotides revealed a significant 13-fold difference: 0.009 ± 0.002 s
-1
 
and 0.116 ± 0.019 s
-1
 respectively (Figure 7B, Figure 19C exponential - fit example), which 
indicates a lower affinity of the M3-R-Go complex. Moreover, since we actually measured the 
interaction of fluorescent Gβγ with fluorescent receptors using overexpressed native Gα 
subunits for a more accurate comparison between receptor-G protein coupling, we also 
performed experiments with fluorescently labelled versions of both Gαq and Gαo as a control. 
No labelling associated differences in the dissociation kinetics for both G proteins were 




Figure 8. The stability of M3-R-G protein ternary complexes was independent of the 
labelling site on the G protein 
The decay kinetics of Gq-M3-R complex dissociation upon agonist withdrawal under 
nucleotide-free conditions (A) were compared when the G protein was (CFP)-labelled on N-
terminus of Gγ or Cerulean-labelled in the helical domain of the Gαq subunit. (B) Dissociation 
kinetics were calculated as described in section 2.2.5. Similar to Gq, the stability of M3-R-Go 
complex was measured by means of FRET (C,D). No significant difference between 
conditions of Gα-labelled and G-labelled G proteins was observed in respect to calculated 
koff values. Statistical analysis was performed by one-way ANOVA with Bonferroni post-hoc 
test (*P < 0.05). 
 
Similarly, long lifetimes of receptor-G protein complexes were observed for other 
receptors such as β1-, β2-, and α2A-ARs as well as TP-R only for G protein subtypes which are 
known to be activated by the respective receptor (Figure 29, Figure 30, Figure 32). Although, 
the binding of Gαs and Gα13 to M3-R was not detected, these G proteins did bind with high 
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affinity to receptors such as β1-, β2-andrenergic receptors (β-AR) and thromboxane TxA2 
receptor (TP-R) in accordance with the literature data. Correspondingly, we could not detect 
G13 or Gs activation via stimulation of M3-R (Figure 9).  
 
Figure 9. Stimulation of M3-R did not result in G13 and Gs activation 
Depicted is the average trace of G13 activation measured by means of FRET (A) in intact cells 
by selective stimulation of either TP-R with U46619 or cotransfected M3-R with ACh. G13 
activation is reflected in a robust increase in YFP/CFP emission ratio under U46619 whereas 
the perfusion of the same cell with ACh led to only a slight change in FRET signal, indicating 
the absence of G13 activation via M3-R. (C) Average FRET signal trace of Gs activation by 
stimulation of β2AR or cotransfected M3-R. No activation of Gs was observed upon M3-R-
agonist application. The absence of difference in M3-R expression levels transfected with Gq 
versus G13 proteins (B) or Gq versus Gs protein (D) were confirmed by [
3
H]-scopolamine 
radioligand binding (section 2.2.2.5). HEK293T cells were transiently transfected as 
described in Table 6 section 2. Data are shown as mean ± SEM, n of each experiment is given 
in brackets. Statistical analysis was performed by one-way ANOVA with Bonferroni post-hoc 




However, we observed a robust agonist-induced FRET signal in cells transfected with Gαo, 
which was comparable in amplitude with signals obtained in Gαq expressing cells (Figure 7A, 
Figure 18A pink vs. black). 
Under these conditions we determined the G protein/receptor expression ratio to be 2- to 6-
fold (Figure 10) and also detected no major alterations of Gβγ expression in dependence of 
the co-expressed Gα subtype (Figure 11). Based on the broad expression profiles of β and γ 
subunits of G proteins in different tissues, we have chosen Gβ1 and Gγ12 subunits for our 
experiments as a prototypical βγ dimer (Dingus and Hildebrandt 2012; McIntire 2009). 
 
 
Figure 10. Quantification of donor vs. acceptor fluorophores stoichiometry 
The individually measured CFP and YFP intensities were calculated as described in section 
2.2.4.4. HEK293T cells were transiently transfected with M1-, M2-, or M3-R and respective G 
proteins (see Table 6, section 1). The red line depicts the YFP/CFP fluorophores intensities 
ratio equal to 1. The ratio was derived from the cells transfected with YFP-β2-AR-CFP 
(Dorsch et al. 2009) as a reference construct, bearing both fluorophores in one molecule 
without exhibiting detectable FRET, which were permeabilized as indicated in Figure 6 . The 
data are represented as mean ± SEM, n of each experiment is shown in brackets. No 
significant differences in stoichiometry within Gq and Gi family proteins were observed when 
the same mAChR was transfected. Statistical analysis was performed by one-way ANOVA 
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Figure 11. Gαq, Gαo and Gβ1γ2 G protein subunit expression in transiently transfected 
HEK293T cells 
Western-blot was performed on the cellular membranes derived from HEK293T cells 
transiently transfected as depicted in the Figures. Gβγ expression (C) levels were compared in 
the absence or presence of coexpression of Gαq (A) or Gαo (B) subunits. The amount of the 
transfected plasmids and detailed antibody list are given in Table 2 and Table 5 respectively. 
Anti-actin monoclonal mouse antibody was used as a loading control after membrane 
stripping. 
 
3.2.2 Verification of effective nucleotide-removal in permeabilized cells 
In experiments studying M3-R interaction with either Gq or Go proteins in the presence of 
high or low concentrations of GDP or GTP we verified accurate control of nucleotides in 
permeabilized cells (Figure 12). Whereas 100 nM concentration of nucleotides led to a 
descending of FRET signal amplitude in response to perfusion with ACh, 100 µM GTP/GDP 
concentration caused the dramatically reduced Gq or almost fully diminished Go protein 




Figure 12. Ternary complex formation and dissociation in presence of low and high nucleotides 
concentration 
Representative traces depict binding of Gq (A,B) and Go (C,D) proteins to M3-R (n=6-10 
similar experiments) measured by means of FRET in single permeabilized HEK293T cells. 
The first stimulation with ACh and the ensuing agonist withdrawal of up to 3 minutes was 
done in absence of nucleotides. The drop in YFP/CFP intensity ratio under the application of 
buffer supplied with low (100 nM) GTP (A,C) or GDP (B,D) concentration reflect the 
dissociation of respective G protein from the receptor. Cells were transfected as indicated in 
Table 6 section 2. 
 
In both Go and Gq transfected cells the response to stimulation of the M3-R with ACh in 
the presence of 100 nM nucleotides was reduced and decreased over time when the agonist 
was still present. The second application of the agonist in presence of low GTP or GDP 
concentrations reached the previous steady-state much faster without a clear decline, which is 
in line with nucleotide binding as a rate limiting state for reaching a fast equilibrium at the 
previous application of agonist. GTP or GDP at a concentration of 100 µM led to a faster off-
rate of the Gq protein from the M3-R. Gq binding to M3-R under stimulation with 10 µM ACh 
in the presence of 100 µM GDP/GTP was much reduced and mimicked the conditions of Gq 
binding to M3-R in intact non-permeabilized HEK293T cells depicted in Figure 6C. After 
wash out of the nucleotides by the rapid buffer exchange perfusion system and following 
stimulation with 10 µM ACh the YFP/CFP emission ratio increased to similar values as in 
response to the initial agonist application for both Gq and Go proteins (Figure 12 A-D). 
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Cells, transiently expressing YFP-tagged M3-R, Gαq-wt or Gαo-wt, Gβ1-wt, and Gγ2–CFP 
were permeabilized by 2 minutes incubation with 0.05% Saponin and released from GTP and 
GDP via several washing steps with internal buffer. Single cells were washed 2 minutes with 
internal buffer via rapid superfusion (< 10 ms) to get the stable baseline. The increase of 
FRET signal was induced by stimulation with 10 µM ACh. The withdrawal of agonist was 
performed by depletion of ACh with a constant superfusion of the cell with internal buffer. 
The overlay of Gq and Go dissociation from M3-R is shown in Figure 13A,C dependent on the 
presence of nucleotides. The dissociation kinetics of Gq but not Go from M3-R were 
significantly accelerated by GTP (Figure 13B,D). The non-significantly different koff values 
for Go-M3-R dissociation kinetics can be explained by low affinity of Gi family proteins to 
M3-R (Figure 18). 
 
 
Figure 13. M3-R-G protein ternary complex stability upon the reintroduction of GTP 
into permeabilized cells 
Illustrated are averaged traces of FYFP/FCFP alterations induced by agonist withdrawal from 
permeabilized cells expressing Gq-CFP (A) or Go-CFP (C) and M3-R-YFP in the presence or 
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absence of 100 nM GTP. HEK293T cells were transfected with M3-R-YFP and Gq or Go 
protein as described in Methods (Plasmid mix. G protein binding). Koff values of the M3-R Gq- 
(B) or Go-protein (D) interaction were determined by fitting an monoexponential decay 
function to individual FRET-decays shown in A and C for both conditions (with or without 
GTP) and were plotted as averaged data. All data are presented as mean ± SEM. Statistical 
analysis was performed by one-way ANOVA with Bonferroni post-hoc test (*P < 0.05). 
 
3.2.3 Preassembly of M3-Rs and Gq, Go proteins under nucleotide-free conditions 
The question whether GPCRs and G proteins preassemble in intact cells is a matter of 
debate (Kuravi et al. 2010). It has been reported in several studies that a precoupling of Gq 
proteins to inactive receptors may exist. The crucial role of M3-R receptor C-terminus in G 
protein-receptor preassembly as well as polybasic region in helix 8 has been revealed (Qin et 
al. 2012). Although, the M3 muscarinic receptor used in previously described assays is 
labelled with the fluorescent protein on the C-terminus which might impair inactive receptor-
G protein precoupling (Qin et al. 2012), I decided to test for the presence of nucleotide-
sensitive pre-association of receptors and G proteins in permeabilized cells. The application of 
GTPγS prior to the agonist did not lead to remarkable decrease in YFP/CFP emission ratio, 
indicating no detectable association either Gq or Go proteins with unstimulated M3-R in the 
developed nucleotide-free FRET-based assay (Figure 14). 
 
Figure 14. Test for nucleotide sensitive agonist-independent M3-R-G protein interaction 
The figure depicts average FRET traces of M3-R-Gq (A) and M3-R-Go (B) interaction under 
nucleotide-free conditions normalized to minimum receptor occupancy state. HEK293T cells 
were transfected as described in Table 6 section 1. In Gq as well as in Go transfected cells the 
application of GTPγS prior to stimulation with the agonist did not lead to a decrease in 
YFP/CFP emission ratio indicating no preassembly of G proteins with M3-Rs after membrane 
permeabilization. All presented data represented as mean ± SEM, with n≥7. 
3.2.4 Calculation of M3-R-Gq and M3-R-Go association kinetics 
Furthermore, we measured the association kinetics of M3-R with Go and Gq proteins 
under nucleotide-depleted conditions in dependence of the agonist concentration (Figure 
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7C,D). Based on generally accepted agonist receptor occupancy models (Kenakin, 2008; 
Pierre, 2011) the rates of receptor-G protein interaction (kobs) should increase with an 
exponential correlation (E4.1) to the agonist concentration applied. Taking into account that 
the exponential function is a subcase of a particular hyperbolic sector, kon was calculated as a 
first derivative of kobs described as hyperbolic function (E4.2). 
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Moreover, the kon values for the Gq and Go and Gi2 were also calculated according to the 
equation E4.3     
   based on the determined koff values and the apparent EC50 values 
measured under steady-state conditions in permeabilized cells (E4.3, Figure 7, Figure 15, 
Figure 16, Figure 17A).  
 
 
Figure 15. Comparison of carbachol-induced Gi2 and Go steady-state binding to M3-R in 
absence of nucleotides 
Agonist concentration dependent binding of Gi2 and Go to M3-R under nucleotide-depleted 
conditions were plotted. HEK293T cells were transiently transfected as described in Table 6 
section 1, permeabilized and stimulated by increasing concentrations of CCh under conditions 
close to steady state. CCh-concentration-response curve for Go binding to M3-R is given as a 
reference similar to the one given in Figure 17A. The amplitudes of increase in YFP/CFP 
emission ratio for both Go and Gi2 were normalized to the response of the cell to saturating 
CCh concentration (1 mM). Curves were fitted according to Hill-Langmuir equation revealing 
EC50= 8.33 ± 0.22 µM CCh with 0.7 Hill-slope for Gi2 and 10.68 ± 0.32 µM CCh with 1.0 
Hill-slope for Go. All concentration-response data is represented as mean ± SEM for each 




Based on results shown in Figure 15 the    
  value for the Gi2 were calculated using 





fold slower as for Go (Table 8).  
Both kon and    









 respectively). We also attempted to experimentally determine the 
on-rate for the M3-R-Go interaction (Figure 16), however in this case the apparent on-kinetics 
were faster and if plotted against the agonist concentration we failed to fit the data to a simple 
one-component hyperbolic function (Table 8).  
 
Figure 16. Calculation of M3-R-Go protein association kinetics measured in 
permeabilized cells 
The observed association kinetics (kobs) values were calculated by direct fitting of an 
exponential curve to the increase in the YFP/CFP emission ratio under application of 
increasing concentrations of CCh and plotted over time. The hyperbolic function was fitted 
separately to low (magenta,    
 ) and high saturating (blue,    
 ) concentrations of agonist. 
The plotted tangents represent the kon values calculated as first derivatives of hyperbolic kobs 
function. The grey tangent line depict the kon for Go-M3-R complex formation calculated 
based on steady-state experiments and measured dissociation kinetics (koff) for the same 
complex. Data are shown as mean ± SEM for each condition, n of each experiment is 




Nevertheless, the measured and calculated association kinetics did not reflect the 
differences in coupling preference for Gq over Go proteins suggesting that at least for the M3-
R probably not the kon but rather the lifetimes of the ternary complex play a major role in the 
determination of receptor-G protein selectivity.  




) for the association of M3-R with Gq, Go and Gi2 
proteins 
      Gq    
  Gq    
  Go    
  Go    
  Go    
  Gi2 
P1 0.03657 -* 0.271 0.1062 -* -* 





) 22.4356 14.0625 210.0775 48.715596 10.861423 6.36 
koff (s
-1
) 0.009 ± 0.002 0.116 ± 0.019 0.053 ± 0.006 
Kd (µM) 0.40115 † 0.55218 2.3812 † † 
EC50 binding (µM) 0.64 ± 0.04 10.68 ± 0.32 8.33 ± 0.22 
EC50 activation (µM) 0.12 ± 0.01 0.79 ± 0.01 - 
P1, P2 - hyperbolic function constants of curve amplitude and steepness (equation E1); 
    - quantified kon value based on kobs data using hyperbolic function fit (equation E2); 
   
 - calculated kon value based on steady-state experiments (equation E3); 
   
  - quantified kon value when higher concentrations of CCh (5 – 100 µM) applied based on 
kobs data using hyperbolic function fit; 
   
 - quantified kon value when lower concentrations of CCh (0.3 – 3 µM) applied based on 
kobs data using hyperbolic function fit;  
*-not hyperbolic fit but Kd calculation was performed; 
†-Kd was assumed to be equal to EC50 binding; 
Empirical data are given as mean ± SEM. 
 
3.2.5 Correlation of G protein affinity to M3-R with their coupling efficiency  
In order to experimentally verify whether the measured kon and koff were realistic, we next 
determined steady-state binding curves for the carbachol-induced nucleotide-free complex 
formation of M3-R with Gαq- or Gαo-containing G proteins in dependence of agonist 
concentration, by determining the stable plateau reached after agonist application (Figure 17A 





Figure 17. Correlation of M3-R-G protein binding and G protein coupling efficiency 
Concentration-response curves of Gq and Go binding to M3-R measured by means of FRET 
under nucleotide depleted conditions (A). Single-cell imaging was performed on 
permeabilized HEK293T cells transiently transfected as described in Table 6 section 1. (B) 
The representative trace of Gq binding to M3-R under application of the sustained increasing 
concentrations of CCh. Due to the slow association kinetics of G protein-M3-R complex under 
application of low concentrations of CCh, the steady-state conditions induced by small 
amounts of agonist were estimated after incubation of the cells for up to 10 min. (C) 
Concentration-response curves of Go and Gq protein activation via stimulation of M3-R were 
measured by means of FRET. Experiments on G protein coupling efficiency were performed 
in 96-well format on cells transfected as described in Table 6 section 2. (D) A representative 
experiment for multiple-cell FRET-imaging of Gq activation under M3-R stimulation with 
different concentrations of CCh is shown (measured in duplicates). Each trace is derived from 
one out of 12-wells stimulated simultaneously with overflow technique. All concentration-
response data are represented as mean ± SEM for each condition, n of each experiment is 
shown in brackets. The amplitudes of agonist-induced amplitudes of FRET signal were 
normalized to the saturating concentrations of CCh (1mM) and in case of G protein binding 
experiments also to the minimum receptor occupancy state (response to GTPγS).  
 
The concentration-response curve of Go binding to M3-R was found to be 16.5-fold right 
shifted in comparison to Gq (EC50 = 10.68 ± 0.32 µM and 0.64 ± 0.04 µM, respectively), 
which indicates a higher affinity of binding of Gq to M3-R compared with Go. 
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In order to test whether the stability of the ternary complex correlates with the efficiency 
of G protein activation, we determined Go and Gq protein coupling efficiency to M3-R (Figure 
17 C,D) by measuring FRET between Gα fused to YFP and CFP-labelled Gβγ subunits 
(Vilardaga et al. 2003) in thousands of non-permeabilized adherent transiently transfected 
cells (Figure 17D) in a 96-well format. Similar to the binding data, the concentration-response 
curve of Gαo activation (EC50 = 0.79 ± 0.01 µM) by M3-R were 6.6-fold right shifted in 
comparison to Gαq activation (EC50 = 0.12 ± 0.01 µM) (Figure 17C pink vs black). 
Considering our findings regarding the on-kinetics of Go and Gq binding to activated M3-R, 
this result shows that the affinity of the mAChRs-G protein interaction underlying G protein 
selectivity is primarily reflected by the stability (lifetime) of the complex and correlates 
closely with the coupling efficiency. In case of G protein activation assays measured by 
means of FRET the transfected receptor was unlabelled. Taking into account the fact that the 
expression levels of the receptor influence the agonist sensitivity of G protein activation, 
radioligand binding assays were performed to compare receptor densities for both conditions, 
which revealed equal expression levels (Figure 9). 
3.2.6 Dissociation rates of different Gi proteins bound to M1-, M2-, and M3-Rs. 
Moreover, we measured dissociation kinetics of M3-R-Gi/o proteins complexes in 
dependence of Gαi subtypes and found no significant differences for Gαi1, Gαi2 and Gαi3 
(Figure 18B). Similar results were obtained for M1-R (Figure 19B,D). 
 
Figure 18. Comparison of the stability of G protein-M3-R complexes 
Decay kinetics of receptor - G protein complexes were determined in response to agonist 
withdrawal for M3-Rs and different members of the Gi/o and Gq protein family in experiments 
similar as shown in Figure 7. (A) Average traces of the FYFP/FCFP ratio of ACh-induced G 
proteins interaction with M3-R under nucleotide-depleted conditions. Examples of exponential 
curve fittings to the decline in the YFP/CFP emission ratio after agonist withdrawal are shown 
in Figure 19C. (B) Quantified constants of dissociation (koff, s
-1
) of Gi1, Gi2, Gi3, Go, and Gq 
proteins (green, orange, violet, magenta, black respectively in all bar-graphs) M3-R are 
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illustrated . Calculated koff (s
-1
) values including the replication numbers (n) are given in Table 
8. The data is represented as mean ± SEM. Normalization of alterations in FRET was 
performed as described in Figure 7. Statistical analysis was performed by one-way ANOVA 
with Bonferroni post-hoc test (*P < 0.05).  
 
 
Figure 19. Dissociation kinetics for interactions between M1-R and specific G proteins 
The time course of Gq, Go, Gs, and G13 (black, magenta, violet, dark red respectively) binding 
to M1-R was measured in response to short periods of exposure to ACh in nucleotide-depleted 
cells (A) by means of FRET. Binding of G proteins reflected as an increase in FYFP/ FCFP ratio 
under application of the agonist (10 µM ACh) was compared to the condition when no Gα but 
empty vector pcDNA3 (dark green) was transfected. Similar to M3-R, we could not observe 
binding of Gs and G13 proteins to M1-R as no differences in the amplitudes or kinetics of the 
FYFP/ FCFP ratio were found compared to M1-R and pcDNA3 co-transfection. Average traces 
represented as mean ± SEM, n of each experiment is indicated in brackets. (B) Dissociation 
kinetics of Gi family proteins from M1-R compared to Gq during the withdrawal of ACh under 
nucleotide-free conditions plotted as mean ± SEM was calculated by fitting monoexponential 
function as shown in (C). The minimum YFP/CFP emission ratio was measured after GTPγS-
induced dissociation of receptor-G protein complexes and was defined as zero. No significant 
difference was observed among Gi family affinities to M1-R when koff values were compared 
(D). Statistical analysis was performed by one-way ANOVA with Bonferroni post-hoc test (*P 
< 0.05).  
To test for the Gi/o subtype selectivity of M2-R, we repeated similar experiments for M2-
R. Here we observed a higher amplitude and slightly enhanced complex stability for Gαo and 
Gαi2 compared to Gαi1 and Gαi3, as the calculated koff  values of Gαo and Gαi2 from M2-R were 
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2-fold smaller in comparison to Gαi1 and Gαi3, a result that correlates with the G protein 
homology within the Gi family ((Milligan and Kostenis 2006) Table 1, Table 8, Figure 20).  
 
Figure 20. Quantification of the stability of M2-R G protein complexes 
Average traces of FRET recordings reflecting ACh-induced Go and Gq binding to M2-R under 
nucleotide-depleted conditions are shown (A). No binding of Gq proteins to M2-R was 
observed as no differences in the amplitudes or kinetics of the FYFP/FCFP ratio were found 
compared to M2-R and pcDNA3 co-transfection. (B) Similar experiments where performed 
with M2-R-YFP to study interactions with Go, Gi1, Gi2, and Gi3 proteins. High or moderate 
increase of FYFP/FCFP ratio under application of ACh was observed for all investigated M2-R-
Gi family protein pairs. Dissociation kinetics of Gi1-, Gi2-, Gi3-, Go-, and Gi proteins from M2-
R (C) during the withdrawal of ACh derived from experiments shown in B were plotted as 
average traces. The minimum YFP/CFP emission ratio was measured after GTPγS-induced 
dissociation of receptor-G protein complexes and was defined as zero. The calculated koff 
values of Go and Gi2 proteins were significantly lower compared to Gi1 and Gi3 constants of 
dissociation (D). The data is represented as mean ± SEM for each condition, n of each 
experiment is given in Table 8. All average traces represented as mean ± SEM, n of each 
experiment is indicated in brackets. Statistical analysis was performed by one-way ANOVA 
with Bonferroni post-hoc test (*P < 0.05). 
 
As expected, also no binding of Gαq to M2-R in absence of nucleotides was detected 
(Figure 20A). A summary of all koff values is given in Table 8. 
Table 8. Calculated koff (s
-1
) for the dissociation of G proteins from mAChRs 
G protein / Receptor M1-R M2-R M3-R 
Gq 0.009 ± 0.003 (6)   -* (5) 0.009 ± 0.002 (27) 
Go 0.104 ± 0.016 (6) 0.029 ± 0.004 (8) 0.116 ± 0.019 (21) 
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Gi1 0.057 ± 0.009 (7) 0.056 ± 0.009 (10) 0.054 ± 0.008 (10) 
Gi2 0.078 ± 0.019 (7) 0.027 ± 0.003 (11) 0.053 ± 0.006 (10) 
Gi3 0.075 ± 0.011 (7) 0.055 ± 0.007 (10) 0.050 ± 0.004 (12) 
Gs   -* (10)   †   -* (6) 
G13   -* (6)   †   -* (6) 
*The binding of the G protein was not detected under described conditions. Data are given as 
mean ± SEM (n cells).  
†The conditions were not tested. 
 
3.2.7 Effect of PTX on G protein binding to M3-R  
Even though several receptors were crystalized in both active and inactive conformations, 
the exact mechanism of G protein-receptor coupling selectivity is still unclear. As it was 
proposed in ternary complex model and later on shown in NMR studies (Kofuku et al. 2012) 
the specific G protein – receptor complex formation is required for the active receptor 
conformation stabilization. Based on recent studies, agonist mediated conformational changes 
in H8 and ICL1 domains of the receptor were suggested to be stabilized by binding of α5 C-
terminus domain of Gα subunit of the specific G protein  (Sounier et al. 2015). We 
hypothesized that Gα C-terminus binding to the active GPCR might play an important role in 
the initial determination of receptor-G protein selectivity. Taking into account that receptor-G 
protein complex stability depends on intracellular nucleotide concentration (Matesic et al. 
1989), we tested the ability of the Gαi protein to bind receptors after Pertussis toxin mediated 
ADP-ribosilation of the C-terminus of Gαi subunit using FRET method in combination with 
the controlled nucleotide concentrations technique. 
 
Figure 21. Gi protein binding and activation after PTX treatment 
Average YFP/CFP emission traces of Gi2 binding to M3-AChR under GTP-depleted 
conditions in PTX-untreated (black) and untreated (violet) cells plotted over time (A). Cells 
were transfected as indicated in Table 6 section 1. The significantly reduced amplitudes of 
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FRET signal upon ACh application in cells incubated with PTX in comparison to PTX-
untreated cells indicate the inhibition of Gi2 binding to the receptor. YFP/CFP emission ratio 
was normalized to receptor minimum occupancy state (GTPγS application). (B) Average 
traces of Gi1 activation via α2A-wt in intact cells reflecting an increase of FRET signal are 
illustrated. Cells were transfected as described in Table 6 section 2. The traces were bleach 
corrected and normalized to initial values. Perfusion of PTX-untreated with 10 µM NA 
(black) leads to receptor-mediated Gi1 activation which was completely diminished by cells 
preincubation with PTX (violet).  All data are represented as mean ± SEM.  
 
Here, we focused on α2A adrenergic receptor and muscarinic acetylcholine receptors M2 
and M3, as GPCRs known to activate inhibitory G proteins. The binding of PTX-inhibited Go, 
Gi1, and Gi2 proteins upon agonist application was investigated by means of FRET-based 
experiments performed in permeabilized cells transiently transfected with M3-YFP or α2A –
YFP and CFP-Gγ2 as a FRET-pairs. We also measured the activation of Gαi1 by α2A -AR as a 
control of PTX functionality. In order to prevent immediate G protein dissociation after its 
binding to the receptor, endogenous nucleotides were depleted by brief exposure of the cells 
to saponin and following washing steps.  
Indeed, binding of the Gi2 to M3-AChR and α2A-AR in permeabilized cells was 
completely abolished by overnight incubation with 50 ng/ml PTX and displayed as 
dramatically reduced FRET amplitudes upon agonist application to PTX-treated cells in 
comparison to untreated cells (вышеFigure 21).  
To sum up, the PTX mediated prevention of Gi binding to the active receptor under GTP-
free conditions allows us to conclude that binding of α5 C-terminus of Gi to H8 and ICL1 
domains of the receptor plays a crucial role in the mechanism of G protein receptor 
selectivity. 
 
3.3 Differences in ligand induced GPCR-G protein interaction dynamics 
3.3.1 Influence of agonist affinity on M3-R-Go and M3-R-Gq complexes stability 
In order to activate mAChRs, we used three different agonists exhibiting different 
affinities and efficacies towards binding and activation: acetylcholine (ACh), its synthetic 
analogue carbachol (CCh), and the partial agonist arecoline (Are) (Stamatiou et al. 2014). 
Thus, we also addressed the question of whether the type of the ligand can affect the affinity 
of the G protein to the receptor. HEK293T cells were transiently transfected and 
permeabilized as mentioned above. Single cells were first stimulated with ACh and, after its 




Figure 22. Stability of M3-R-G protein complexes induced by different agonists 
Comparison of the averaged decay kinetics of Gq- (A) and Go- (C) dissociation from M3-R 
under the withdrawal of the agonist when the formation of the respective ternary complex was 
induced by either acetylcholine (ACh, black), carbachol (CCh, purple) or arecoline (Are, 
blue). FRET signal was measured on single permeabilized cells transfected as described in 
Table 6 section 2. The lifetime of the Gq-M3-R ternary complex (B) as well as Go-M3-R (D) 
induced by different agonists were found to be similar. The data is shown as mean ± SEM for 
each condition, n of each experiment is shown in brackets. The traces were normalized to the 
saturating concentrations of the ligands and to the minimum receptor occupancy state 
corresponding to the YFP/CFP emission ratio values in presence of GTPγS. Statistical 
analysis was performed by one-way ANOVA with Bonferroni post-hoc test (*P < 0.05). 
This procedure allows a comparison of the dissociation kinetics of G proteins-receptor 
complexes in the same cell, meaning equal expression levels of interacting proteins. We 
observed similar dissociation rates of Gq from ACh-, CCh-, and Are-activated M3-R (Figure 
22 A,B). Relatedly, the dissociation kinetics of Go from M3-R were not significantly different 
for all three agonists (Figure 22 C,D). Thus, we could conclude that, at least in the case of 
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agonists with moderate to low affinity, the stability of the G protein-receptor complex is an 
intrinsic property of the mAChR-G protein pair and not influenced by the agonist affinity. 
3.3.2 Determination of effects of partial, full and super agonists on the dynamics of 
GPCR-G protein interactions  
In this research project, I investigated whether the degree of partial/full agonism can be 
quantified as the kon of the M1-R-Gq complex and be used for the ligands characterization. In 
order to check this hypothesis we calculated the correlation coefficient based on three ligand 
parameters: 1) association rate of the GPCR-G protein complex induced by the ligand under 
nucleotide-free conditions, 2) Kd value of the ligand reflecting its affinity to the receptor, and 
3) efficiency of the ligand to activate the G protein via the receptor. 
I calculated the lifetime of M1-R-Gq complex induced by pilocarpine compared to ACh 
and the super agonist Iperoxo (Ipx) in the conditions of nucleotide depletion. In contrast to 
ACh and pilocarpine, activation of the M1-R by superagonist iperoxo led to the formation of 
M1-R-Gq complex with an enhanced lifetime (Figure 23 C, D). However, the G protein 
binding rate induced by Ipx and ACh was not significantly different, whereas under 
pilocarpine application Gq-M1-R association kinetics was remarkably slower (Figure 23A,B). 
In this context the on-rate of M1-R-Gq interaction under nucleotide depleted conditions was 
suggested to depend not only on the affinity of the G protein to the receptor but mostly on the 
amount of the receptors stabilized in the active conformation at the particular time point. The 
stabilization of the receptor in the active conformation preferable for the G protein binding 
might elucidate the mechanism of action for the weak and superagonists.  
Concentration-response curves of Gq activation by M1-R mediated by ligands of interest 
was measured in intact cells using established G protein FRET assays with the help of 
recently developed multiple-cell FRET measurement approach (Professor H. Lemoine, 
Heinrich Heine University, Düsseldorf, Germany). HEK293T cells were transiently 
transfected with plasmids for FRET-based G protein activation assay as described in Wolters, 
et al., 2015. All responses are normalized as previously mentioned to the final application of 
CCh in saturating concentration (Figure 24). 
In summary, the combination of Kd value, EC50 of efficiency in G protein activation and 






Figure 23. Dynamics of M1-R Gq protein complexes induced by the partial agonist 
pilocarpine  
The figure depicts comparison of the (A) on- and (C) off-set kinetics of Gq binding to M1-R 
under nucleotide conditions induced by either pilocarpine (blue, n=4), acetylcholine (violet, 
n=4) or iperoxo (purple, n=4) measured by FRET. HEK293T cells were transfected as 
described in Table 6 section 1. The constants of (B) association (kon, s
-1
) and (D) dissociation 
(koff, s
-1
) of M1-R-Gq complexes induced by different agonist were calculated as indicated in 
Figure 22. Pilocarpine (blue) mediated Gq binding to M1-R under nucleotide depleted 
conditions was significantly slower when compared to the application of both ACh (violet) 
and Iperoxo (purple). Interestingly, intrinsic Gq protein affinity to pilocarpine-activated M1-Rs 
was similar to the ACh-activated receptors, whereas Iperoxo induced higher M1-R-Gq protein 
complex stability. All data are plotted as mean ± SEM for each condition. Statistical analysis 
was performed by one-way ANOVA with Bonferroni post-hoc test (*P < 0.05). 
Based on the results of ligand-induced M1-R-Gq ternary complex association (kobs) and 
dissociation (koff) kinetics and the data on Gq protein activation (Figure 24), we can suggest 
that the degree of probability for the receptor to be stabilized in the active conformation with 
the agonist reflects in receptor-G protein association under nucleotide-depleted conditions and 
correlates with this agonist efficiency. kon of ternary complex induced by different agonists 
was calculated by using the following equation:  
 𝑜  ( 𝑜    𝑜  )  (      𝑜  )                                   (E5.1) 
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The kon values for all tested agonists are given in Table 9. Moreover, the respective kon 
values were also calculated based on experiments performed in membranes derived from 
transiently transfected cells (Table 10, Professor H. Lemoine, Heinrich Heine University, 
Düsseldorf, Germany). Membranes preparation was performed as described in section 2.2.2.3. 
 
Table 9. Calculated kon of M1-R-Gq ternary complex induced by different agonists in 
permeabilzed cells. 





Choline 1 mM 3.0 0.01041 ± 0.00117 (13) 0.00918 ± 0.00118 (11) 0.00123 
Bethanechole 100 µM 4.0 0.01423 ± 0.00086 (12) 0.01056 ± 0.00096 (12) 0.00367 
Pilocarpine 30 µM 4.5 0.01281 ± 0.00078 (12) 0.00333 ± 0.00062 (12) 0.00948 
Methacholine 10 µM 5.0 0.02310 ± 0.00207 (12) 0.00399 ± 0.00083 (12) 0.01911 
Arecoline 10 µM 5.0 0.03482 ± 0.00810 (10) 0.00452 ± 0.00093 (10) 0.03030 
Carbachol 10 µM 5.0 0.04691 ± 0.02925 (11) 0.00540 ± 0.00098 (7) 0.04151 
Acethylcholine 10 µM 5.0 0.08723 ± 0.00601 (7) 0.00317 ± 0.00069 (9) 0.08406 
Iperoxo 1 µM 6.0 0.13012 ± 0.00254 (8) 0.00432 ± 0.00094 (10) 0.12580 
The agonists are ordered from the lowest to highest kon values,  
    - quantified kon value based on kobs and koff data calculated as indicated in E5.1. Empirical 
data are given as mean ± SEM, the number of analysed experiments is given in brackets (n). 
 
Table 10. Calculated kon of M1-R-Gq ternary complex induced by different agonists in 
membranes. 





Carbachol 10 µM 5.0 ±   
 
Bethanechole 10 µM 5.0 0.02845 ± 0.00527 (11) 0.01207 ± 0.00048 (7) 0.01638 
Pilocarpine 3 µM 5.5 0.03349 ± 0.00337 (12) 0.00767 ± 0.00032 (10) 0.02582 
Choline 1 mM 3.0 0.05007 ± 0.00245 (19) 0.01414 ± 0.00042 (20) 0.03593 
Arecoline 3 µM 5.5 0.04903 ± 0.02579 (7) 0.00798 ± 0.00029 (4) 0.04105 
Arecoline 3 µM 5.5 0.05725 ± (7) 0.00996 ±(4) 0.04730 
Methacholine 3 µM 5.5 0.09350 ± 0.00688 (7) 0.01200 ± 0.00023 (7) 0.08150 
Acetylcholine 100 µM 4.0 0.12120 ± 0.03176 () 0.01565 ± 0.00065 () 0.10556 
Bethanechole 30 µM 4.5 0.12508 ± 0.00751 (19) 0.00495 ± 0.00028 (18) 0.12013 
Acetylcholine 30 µM 4.5 0.14270 ± 0.02750 ()  0.01340 ± 0.00110 ()  0.12928 
The agonists are ordered from the lowest to highest kon values,  
    - quantified kon value based on kobs and koff data calculated as indicated in E5.1. Empirical 






Figure 24. Activation of Gq protein via M1-R induced by different agonists 
The activation of the G protein (Wolters, et al, 2014) via stimulation of M1-R with agonists 
exhibiting different potencies was measured using multiple cell FRET assays. HEK293T cells 
were transiently transfected as described in Methods (G protein activation plasmid mix). 
Transfected cells were transferred to 12-well strips coated with poly-L-lysine. Ligands were 
applied using 12-well injection blocks. The artifacts were reduced by holding a constant 
temperature of the whole system (24  C). All data are plotted as mean ± SEM for each 
condition. 
 
As previously mentioned, our study focused mainly on M1-R-Gq dynamic interactions. 
However, the family of muscarinic acetylcholine receptors also include classical Gi binding 
GPCRs such as M2- and M4Rs (J Wess et al. 1995). The affinity of Gi family protein to M2-R 
was shown to be quite low in comparison to stable ternary complexes of other GPCRs binding 
their typical interaction G protein partners (Figure 20). Furthermore, in pilot experiments for 
this study, we used iperoxo as a superagonist to activate mAChRs (Schrage et al. 2014; 
Fredriksson et al. 2003). In contrast to M1-Rs which exhibited moderate increase in the Gq 
protein affinity mediated by iperoxo (Figure 23), M2-R-Go complex stability induced by 
iperoxo was found to be 7-fold higher compared to ACh (Figure 25). This phenomena of 
superagonist induced stabilization of M2-Rs correlates with the literature data (Kruse et al. 
2013).  
Taken together, the experiments help to understand the underlying mechanisms of the 





Figure 25. Comparison of the Iperoxo- and ACh-induced M2-R-Go complex stability 
The average traces of the YFP/CFP emission ratio show the dissociation kinetics of the Go 
proteins from M2-R during the wash out of the agonist under nucleotide-depleted conditions 
(A) M2-R was activated by either 10 µM ACh or 10 µM Iperoxo (dissociation of the Go 
protein shown in violet (n=7) or purple (n=7) respectively). HEK293T cells were transiently 
transfected as indicated in Table 6 section 1. (B) Go affinity to M2-R was quantified as 
dissociation kinetics (koff, s
-1
) of the Go protein from M2-R under nucleotide free conditions as 
performed in Figure 19C. In comparison to ACh, the M2-R-Go ternary complex stability 
induced by Iperoxo was significantly higher.  The data is represented as mean ± SEM. 
Statistical analysis was performed by one-way ANOVA with Bonferroni post-hoc test (*P < 
0.05).  
 
3.3.3 The examination of allosteric ligands effects on mAChR-G protein interaction 
kinetics 
Muscarinic receptors expose a high degree of sequence similarity within the orthosteric 
binding pocket, making the development of receptor-specific ligands very difficult. Therefore, 
pharmaceutical research is now shifted to generation of allosteric agents, which can modulate 
receptor activity subtype-specifically, by targeting non-conserved extracellular regions of the 
GPCR (Baltos et al. 2016; Birdsall and Lazareno 2005; Katie Leach, Sexton, and 
Christopoulos 2007). Moreover, since substances only regulate receptor signalling in the 
presence of natural agonists, the application of allosteric modulators as therapeutical agents 
potentially result in a reduction of adverse reactions (May et al. 2007). 
In this study, BQCA, known to be a selective positive allosteric modulator (PAM) for 
M1-R, was used as a positive allosteric modulator (PAM) for the pilot experiments. 
In section 3.3.2 it was shown that the agonist efficacy correlated with the probability of 
mAChR – G protein complex formation. Here I measured the stability of M1-R-G protein 
complexes induced by ACh in the presence of BQCA in permeabilized cells. Gq protein 
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(Figure 26A,B) dissociation kinetics from M1-R in presence of BQCA during the withdrawal 
of agonist were slower in comparison when only buffer was used. Similar results were 
observed for Go-M1-R complexes stability (Figure 26C,D). Interestingly, the application of 
BQCA led to the enhancement of Gq and Go affinities to M1-Rs under nucleotide depleted 
conditions up to the ones induced by iperoxo.   
Thus, positive allosteric modulator BQCA not only increases the affinity of M1-R to 
ACh, but also increases Gq protein affinity to the M1-R in concert with ACh, indicating a 
distinct active M1-R conformation. It suggests that this allosteric modulator increases the 
probability of the receptor to be stabilized in active conformation by particular agonist.  
 
Figure 26. BQCA increases the stability of both M1-R-Gq and M1-R-Go complexes 
Dissociation of Go or Gq proteins from M1-R was measured by means of FRET in response to 
agonist withdrawal under conditions of nucleotide depletion. Average traces of YFP/CFP 
emission ratio reflecting FRET between YFP labeled M1-R and CFP-labeled Gγ2 subunit 
show the dissociation rate of Gq (A) or Go (C) from M1-R. The binding of the G proteins to 
the receptors was induced by application of 10 µM Iperoxo (purple, n=7), 10 µM ACh in 
absence (violet, n=5) or presence of 1 µM BQCA (orange, n=7). The difference between Gq 
protein affinity to the M1-R activated by Iperoxo and ACh was almost completely diminished 
by stimulation of the receptor with ACh in presence of positive allosteric modulator BQCA. 
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The constants of dissociation (koff, s
-1
) for Gq (B) and Go (D) proteins from M1-R were 
calculated by fitting a monoexponential function as described in Figure 19C. All data are 
plotted as mean ± SEM for each condition. Statistical analysis was performed by one-way 
ANOVA with Bonferroni post-hoc test (*P < 0.05). 
Interestingly, being an allosteric modulator, BQCA was able to induce Gq protein 
binding to M1-R in absence of any orthosteric agonist under nucleotide-depleted conditions. 
In multi-cell FRET experiments, BQCA alone also led to the activation of small but 
significant G protein fraction (Figure 27). Thus, BQCA is suggested to act as M1-R partial 




Figure 27. BQCA effect on M1-R induced Gq activation 
G protein activation was measured by means of multiple cell FRET assay. HEK293T cells 
were handled as described in Table 6 section 2.  M1-R was stimulated with ACh (A), CCh (B), 
Iperoxo (C), and Pilocarpine (D) alone (grey), in presence of 1 µM BQCA (magenta) or 3 µM 
BQCA (dark blue). The starting values of the Gq activation concentration-response curves in 
presence of BQCA were normalized to the effect of BQCA applied without agonist. All data 
points are presented as mean ± SEM 
In my research project, I also tried M1-R-specific negative allosteric modulator 
Gallamine. The addition of Gallamine to the buffer during withdrawal of agonist did not lead 





Figure 28. Lifetimes of mAChR - G protein complexes in presence of the negative 
allosteric modulator Gallamine 
Comparison of Gq (A,B) and Go (C,D) dissociation kinetics from M1-R after withdrawal of 
ACh was measured in absence (black) or presence (violet) of 1 µM Gallamine under 
conditions of nucleotide depletion. Calculated stabilities (koff) of the M1-R-Gq complex as 
well as the M1-R-Go complex were not significantly different. Similar results were observed 
for M3-R-Gq (E, F) and M2-R-Go (G, H) ternary complex stabilities. Averaged data are 
represented as mean ± SEM for each condition, n of each experiment is shown in brackets. 
The minimum state of the receptor is settled to 0 and corresponds to the FRET signal in 
presence of GTPγS. Statistical analysis was performed by one-way ANOVA with Bonferroni 
post-hoc test (*P < 0.05). 
 
3.4 Dynamics and selectivity of G protein binding to other GPCRs 
3.4.1 G protein binding to α2A-, β1-, and β2-adrenergic receptors 
Adrenergic receptors play an important role in physiological processes and are of great 
interest for the pharmaceutical industry as potential drug targets for treating asthma, and 
cardiovascular diseases such as hypertension and antiarrhythmia. Interactions of members of 
the Gi protein family with α2A-AR were measured by means of FRET under nucleotide-free 
conditions. Since α2A-AR is a classical Gi coupled receptor, the detection of specific Gq 
binding to this receptor was not expected (Figure 29A). In line with this expectation the 
agonist-evoked increase in FRET between labelled α2A-AR and G was not increased when 
Gαq was cotransfected instead of empty pcDNA3. In fact the response was even reduced, 
presumably by competition with endogenous Gαi/o subunits for binding fluorescent G 
(Figure 29A). In contrast, co-expression of Gi enhanced the agonist evoked FRET signal 
(Figure 29A). The affinities of Gi1, Gi2 and Gi3 to α2A-AR were quantified by fitting 
exponential function to G protein decay kinetics (Figure 29B) under the withdrawal of NA. 
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The Gi3-α2A-AR complex stability was higher in comparison to Gi1-and Gi2-α2A-AR 
complexes (Figure 29C). 
 
Figure 29. Formation and stability of ternary complexes of α2A-AR-Gi proteins 
G proteins binding to α2A-AR (A) were measured by means of FRET in permeabilized 
HEK293T transiently transfected with α2A -YFP, Gαi1-wt (green), Gαi2-wt (orange), Gαi3-wt 
(blue), Gαo-wt (magenta), Gαq-wt (black) or pcDNA3 (light green), Gβ1-wt and CFP-Gγ2. 
Average YFP/CFP emission ratios for all conditions were plotted over time. Under the 
application of 10 µM Noradrenaline (NA) specific Gi1, Gi2, Gi3 and Go binding to the receptor 
was observed whereas the Gq binding was not detected when compared to pcDNA3. (B) The 
amplitudes of FRET signal evoked by NA were compared. (C) Dissociation kinetics of Gi1, 
Gi2, Gi3, and Go from α2A-AR under nucleotide depleted conditions and calculated as koff 
values by fitting a monoexponential curve (D). The values are shown as mean ± SEM. 
Significance level was determined by one-way ANOVA with Bonferroni post-hoc test (*P < 
0.05). 
By testing the formation of β2-AR – Gs complex formation in absence of nucleotides, no 
change was observed in FRET signal upon stimulation of the receptor by isoproterenol. 
However, the reintroduction of nucleotides to the cell membrane (GTPγS) led to a dramatic 
decrease in YFP/CFP emission ratio below the initial base line at the beginning of the 
measurement (Figure 30A). It suggests the binding of G – protein to the receptor prior to 
agonist introduction, which correlates with the studies on high β2-AR basal activity (Yao et al. 
2009). In the case of β1-AR, the superfusion of the cell with isoprenaline evoked a relatively 
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high increase in FRET signal, indicating agonist-induced Gs binding to the receptor (Figure 
30B).  
It has been shown in multiple studies in cardiac tissues that in contrast to β1-AR selective 
activation of β2-AR leads to myocyte apoptosis only in the case of Gi inhibition by PTX (Xiao 
2001; Devic et al. 2001) which might be interesting for the pharmacological treatment of 
ischemia and heart failure. Therefore, apart from Gs binding, I also tested the interaction of Gi 
proteins with β- adrenergic receptors under GTP-free conditions. Rapid increase in YFP/CFP 
emission ratio under application of 10 µM Iso depicted in Figure 30C suggests agonist-
dependent Go and β2-AR interaction and corresponds well with literature data (Strohman et al. 
2019). Interestingly, I have also detected Go binding to β1-AR in absence of nucleotides 
(Figure 30D). 
According to the literature data Gi activation via β2-AR is less efficient (Strohman et al. 
2019). The same was observed in my experiments. Dissociation kinetics of Go from both β2-
AR and β1-AR is faster indicating its lower affinity to β-adrenergic receptors in comparison to 




Figure 30. β-adrenergic receptor-G protein complexes 
Single cell YFP/CFP emission ratio of isoprenaline-induced Gs binding to β2-AR (A) and β1-
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AR (B) was measured in absence of nucleotides. Small increase in FRET signal under 
stimulation of β2-AR with Iso and rapid decrease under application of GTPγS stands for a 
high basic activity of the receptor. Both β2-AR and β1-AR showed a very strong affinity to Gs 
which reflected in dramatically slow dissociation of the G protein from these receptors during 
ligand withdrawal. (C) Average YFP/CFP intensities ratio of Go binding to β2-AR upon 
isoprenalin application under nucleotide-free conditions. (D) Representative trace depicts 
isoprenalin induced Gi2- β1-AR ternary complex formation in absence of nucleotides. All 
represented data were normalized and if averaged shown as mean ± SEM for each condition. 
 
3.4.2 Binding of Gi and Gq proteins to Endothelin B receptor  
For the following experiments I used HEK293T cells transiently transfected with ETBR-
YFP and heterotrimeric Gi or Gq proteins labelled with CFP on the Gγ subunit as described in 
the Methods part. In order to account for the endogenous expression of Gi family proteins in 
HEK293T, empty vector pcDNA3 was transfected instead of Gα subunit as a negative control 
for the specificity of the G protein-ETBR binding measured by means of FRET between 
receptor and G. The experiments were done under nucleotide-depleted conditions. As 
expected from the literature, agonist-induced binding of Gi1 protein to ETBR lead to the higher 
increase in the FYFP/FCFP ratio compared to Gq (Figure 31). 
 
 
Figure 31. Stability of ETBR-G protein complexes 
(A) Representative YFP/CFP emission ratio of Gi1 and Gq binding to ETBR induced by ET-1 
under nucleotide-free conditions. High Gi1 affinity binding to ETBR results in very slow 
dissociation kinetics of G protein during agonists wash out. (B) Average YFP/CFP emission 
ratio of Gi1 and Gq binding to ETBR depicts also a small initial increase in YFP/CFP emission 
ratio under application of agonist in presence of 1 µM GTPγS and reduced amplitude of the 
response to the final application of GTPγS. All represented data were normalized and if 
averaged shown as mean ± SEM for each condition, with n of least 6 independent experiment. 
 
Interestingly, the GTPγS-triggered Gi1 protein activation and its dissociation from ETBR 
did not result in complete ternary complex degradation (Figure 31A). We repeated the 
experiment with an altered protocol. Application of agonist in presence of nucleotides led to 
74 
 
ETBR-Gi1 ternary complex formation but not ETBR-Gq (Figure 31B), which shows a very high 
affinity of Gi1 protein to the ETBR. Moreover, these results are in accordance with literature 
data and computational experiments claiming that agonists with a very high affinity to the 
receptor, such as endothelin 1, increase the affinity of G protein to GTP (DeVree, et al., 
2016).  
3.4.3 Investigation of GPCR-G protein selectivity in high affinity GPCR-G protein 
complexes  
Although, nucleotide-free conditions allowed the lifetime of ternary complexes to be 
prolonged, the quantification of dissociation rates of the G proteins exhibiting very high 
affinities to certain GPCRs in absence of nucleotides is limited by experimental restraints 
regarding the stability of FRET recordings on cover slips. Based on mAChRs as a model 
system we were able to quantify ternary complex stability and proved the intrinsic affinity of 
G proteins to the active receptor to be a major determinant of their coupling efficiency. In this 
study we modulated the stability of ternary complex by low GTP concentrations.  
3.4.3.1 G protein selectivity of thromboxane A2 receptor  
The differences in G12, G13, and Gq protein affinity to thromboxane TP-R were depicted 
by calculating the koff values in the presence of nucleotides in nM concentration range. 
Interestingly, G13 was found to have more than a 4-fold higher affinity to the TP-R under 
nucleotide depleted conditions compared to Gq (Figure 32), which has reflected in steady-state 
experiments under nucleotide-free conditions as a 5-fold difference of EC50 of G13 and Gq 
binding to TP-R and correlated with coupling efficiency (Figure 33). The determined 




Figure 32. Modulation of the lifetime of Gq-, G13- and G12 - TP-R complexes  
Average YFP/CFP emission ratio traces of G13 binding to TP-R after nucleotide depletion (A) 
was compared to binding of endogenous G proteins. As no difference to negative control 
(pcDNA3 transfection instead of Gα subunit) was observed, Gs did not bind to TP-R. 
Dissociation rate indicate for a high stability of G13-TP-R complex and it was modulated by 
application of different GTP concentrations (B). Comparison of dissociation kinetics of Gq, 
G13 and G12 proteins from TP-R in presence of 25 nM GTP (C) and their calculated koff values 
(D) revealed the 5-fold difference in Gq and G13 affinities to TP-R. Interestingly, Gq and G12 
affinities were found to be similar. All data shown as mean ± SEM for each condition, with n 
≥7 independent experiments. The minimum receptor occupancy state is settled to 0 and 
corresponds to the FRET signal in presence of GTPγS. Statistical analysis was performed by 





Figure 33. Binding of G12, G13 and Gq to TP-R in dependence of agonist concentration 
Concentration – response curve of U46619 induced Gq binding to TP-R (EC50= 6,82 ± 0,08 
nM U46619) under GTP-depleted conditions (A) measured by means of FRET (B) is 6-fold 
right shifted when compared to G13 binding (EC50= 35,94 ± 0,13 nM U46619). The factor 
difference in EC50 correlated with the difference in koff values. All data shown as mean ± SEM 
for each condition, with n ≥6 independent experiments. 
 
The dissociation kinetics data on G13 and Gq protein binding to TP-R under nucleotide 
depleted conditions correlates with the coupling efficiency of these G proteins which has been 
previously described in Bodmann et al. 2017. Thus, the quantification of intrinsic G protein 
affinity to the receptor determines the GPCR degree of selectivity not only for mAChRs but 
also for other types of GPCRs. 
 
Figure 34. Binding of Go to TP-R under nucleotide-depleted conditions 
Mean traces of  YFP/CFP intensities ratio of Go binding to TP-R after nucleotide depletion are 
compared to binding of endogenous G proteins (pcDNA3, negative control) and G13 (positive 
control). Go binding to TP-R was observed but differed from pcDNA3 condition only by fast 
dissociation kinetics after agonist withdrawal. The data is represented as mean ± SEM for 
each condition. The minimum state of the receptor is settled to 0 and corresponds to the FRET 
signal in presence of GTPγS. 
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Next, I investigated the interaction of TP-R with members of the Gi family, in particular 
with Go, under conditions of nucleotide-depletion (Figure 34, Figure 35). In order to increase 
the number of Ns and calculate the difference in G13 and Go interaction kinetics with TP-R, 
the experiments depicted in Figure 34 were repeated. Unfortunately, interactions between Go 
and TP-R were only observed in a few instances, whereas the majority of cells did not 
respond (Figure 35A, B). The possible explanation is the difference in the endogenous G 




Figure 35. Test for interaction of TP-R with members of the Gi family under conditions 
of nucleotide-depletion 
Averages of normalized YFP/CFP emission ratio traces (upon 430 nM excitation) of agonist-
induced binding of Gi1, Gi2, Gi3, Go and G13 to TP-R in the absence of nucleotides (A) are 
depicted. Go binding to TP-R was detectable but differed from pcDNA3 condition only by 
fast dissociation kinetics after agonist withdrawal. The data is represented as mean ± SEM for 
each condition. The minimum state of the receptor is settled to 0 and corresponds to the FRET 
signal in presence of GTPγS. (B) Representative YFP/CFP emission ratio trace of the Go 
binding to TP-R under nucleotide conditions. Application of U46619 triggered the Go binding 
to TP-R. Dissociation of Go was rather fast, as previously was observed with mAChRs. (C) 
Individual traces of YFP and CFP intensities reflecting the change in FRET signal depicted in 
B. 
 
Although, on average no specific binding of Gi family proteins to TP-R were observed, 
the activation of Go via TP-R was shown by means of FRET G protein activation assay 
(Figure 36). The amplitudes of Go activation traces were comparible with G13 activation under 




Figure 36. Activation Go protein via TP-R 
YFP/CFP emission ratio traces of U46619-induced activation of Go and G13 via TP-R (A) 
were obtained in intact cells and are plotted as mean ± SEM normalized to initial values for 
each condition. HEK293T cells were transiently transfected with TP-R labelled with mVenus 
and G proteins labelled with CFP on Gβγ subunit as described in Table 6 section 2.  
 
I also tested the stability of TP-R-G13 ternary complex induced by a different agonist. The 
partial agonist Daltroban was chosen as a ligand with high affinity but low potency for TP-R 
(Figure 37) (Bertolino et al. 1997; John, Colpaert, and Valentin 1998; Miki, Kase, and Ishii 
1992). The Daltroban concentration-response curve was right shifted compared to U46619 
(Figure 37A) whereas no difference in U46619- or Daltroban-induced TP-R-G13 complex 
stability was observed (Figure 37B). 
 
 
Figure 37. Binding of G13 to TP-R induced by Daltroban 
(A) Concentration – response curve of G13 binding to TP-R induced by U46619 (EC50= 6.82 ± 
0.08 nM) and Daltroban (EC50= 65.84 ± 1.9 nM under GTP-depleted conditions were 
measured by means of FRET. (B) G13 dissociation from TP-R stimulated with U46619 
compared to those stimulated with Daltroban was measured under nucleotide-free conditions 
and shown as average traces. The data is represented as mean ± SEM normalized to receptor 





3.4.3.2 Characterization of µ-OR-Gi proteins complex stability  
One of the aims of this dissertation/my research was to investigate the µ-OR selectivity 
for different G subunits. It is still unknown, which of the G proteins has the highest affinity 
to the µ-OR. I focused on Go, Gi1 and Gi2 members of Gi family. In order to determinate that, 
FRET measurements were performed on HEK293T cells transiently transfected with µ-OR-
YFP, G1, CFP-G2 and either Go, Gi1 or Gi2 constructs.  
The binding of Gi proteins to the µ-OR was measured under GTP-depleted conditions on 
single HEK293T cells, transfected with three different G subunits: Go, Gi1, Gi2. Following 
washing steps with internal buffer ensured the depletion of nucleotides through saponin 
mediated pores. FRET changes under the application GTPγS, 10 µM DAMGO and 20 nM 
GTP modulating concentration were observed in all conditions (Figure 38).   
 
Figure 38. Example traces of Gi1, Go, and Gi2 binding to µ-OR in permeabilized cells 
The figure represents individual FYFP / FCFP ratios of single cells transfected with µ-OR-YFP 
and Gi1, Go or Gi2 proteins labelled with CFP on the Gγ2 (A, C, E) and their individual FYFP 
and FCFP intensities (B, D, F).  
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The overlaid traces of Gi1 protein binding to µ-OR are depicted in Figure 39A. I also 
tested the interaction of Gs protein with µ-OR by means of FRET in absence of nucleotides 
(Figure 39B). Although the application of saturating concentrations of DAMGO induced 
increases in the YFP/CFP emission ratio when Gαs was cotransfected with the receptor, the 
amplitude of the response evoked in cells with no transfected Gα (pcDNA3 plasmid 
replacement) was also similarly high probably due to high expression of endogenous Gi 
family protein in HEK293T batch of cells used in this study. However, the increase in the 
YFP/CFP emission ratio of the conditions mentioned above was significantly lower in 




Figure 39. Test for binding of Gs proteins to µ-OR under nucleotide-free conditions 
The figure (A) depicts an average YFP/CFP emission ratio of Gi1 binding to µ-OR under 
nucleotide-depleted conditions. Single-cell FRET recording was done in HEK293T cells 
transfected with µ-OR-YFP and G protein subunits. (B) In comparison to Go transfected cells 
and cells transfected with pcDNA3 instead of Gα, no binding of Gs to µ-OR under nucleotide-
depleted conditions was detected. Data are normalized to minimum and maximum receptor 
occupancy state and presented as mean ± SEM. 
 
GTPγS was applied twice: at the beginning and at the end of each experiment for further 
bleaching correction by receptor minimum state (receptor with no G protein coupled). 
Decrease in YFP/CFP emission ration under initial application of GTPγS prior to agonist 
application as well as a relatively small increase in YFP/CFP emission ratio under application 
of 10 µM DAMGO and dramatic response to the final addition of GTPγS indicates high basal 
interaction of Go with µ-OR in the absence of nucleotides. This can be explained by the 
known high degree of µ-OR basic activity (Huang et al. 2015). The level of intrinsic affinity 
of the Gi family proteins to µOR was calculated as koff of the ternary complexes. Due to the 
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high affinities, observed in previous experiments, the off-rate of FRET response upon wash 
out of the agonist has to be accelerated. Therefore, 20 nM GTP was applied during second 
agonist wash-out to achieve the rate of G protein-receptor dissociation optimal for 
quantification. Calculated koff of Gi1, Gi2 and Go were found to be not significantly different, 
which indicates similar affinities of these Gi family proteins to µ-OR (Figure 40). 
 
Figure 40. Dissociation kinetics of Gi1, Gi2 and Go from µ-OR 
Off-rates of Gi1 (green curve), Gi2 (blue curve) and Go (red curve) from µ-OR (A) were 
determined after withdrawal of 10 µM DAMGO in the presence of 20 nM GTP (to 
moderately shorten complex lifetimes). Data are plotted as mean ± SEM. The traces were 
normalized to maximum (10 µM DAMGO) and minimum (GTPγS). (B) Calculated 
dissociation kinetics (koff) for HEK293T cells transfected either with Go (n=5), Gi1 (n=5) or 
Gi2 (n=6) are illustrated. The values are shown as mean ± SEM. Significance level was 
determined by one-way ANOVA.  
 
 
Figure 41. Agonist independent association of µ-OR with different G proteins 
To test for the agonist independent association of µ-OR with the indicated G protein subtypes 
induced by nucleotide depletion (A), the amplitude of the decrease in FYPF / FCFP ratio upon 
GTPS (1 µM) application was determined and plotted as averaged data for Go (n=5), Gi1 
(n=5) and Gi2 (n=6) proteins. Kinetics of the FRET increase reflecting association (kobs) 
between µ-OR and Go, Gi1, and Gi2 proteins were measured after application of internal buffer 
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(B). Data are normalized to maximum (FYFP / FCFP ratio in presence of 1 µM DAMGO) and 
minimum (FYFP / FCFP ratio upon final application of GTPγS) receptor occupancy state as 
depicted in Figure 39A. The values are shown as mean ± SEM. Significance level was 
determined by one-way ANOVA.  
 
Under the initial application of GTPγS a fast decrease of the FRET signal indicates the 
dissociation of G protein-receptor complexes which have formed right after permeabilization 
in absence of agonist. Although, the kobs of DAMGO-independent G protein-receptor 
association were similar for all proteins (Figure 41B), the amplitude of the GTPγS triggered 
Gi1 protein dissociation from the µOR was found to be significantly different from Gi2 and Go 
(Figure 41A). This defines the higher stability Gi2-, Go-µ-OR complexes compared to Gi1.  
It has been previously shown in Figure 29, that no difference in Gi3 and Go affinity to α2A-
AR was revealed, probably due to the high stability of their ternary complexes. Therefore, the 
dissociation rate was accelerated by the addition of low GTP concentrations as described for 
TP-R and µ-OR. Interestingly, the significant difference in the affinities of Gi3 and Go to α2A-
AR was observed in presence of low GTP concentration (Figure 42). 
 
 
Figure 42. α2A-AR - Gi protein complex stability in presence of low GTP concentrations 
Representative trace of Gi3 binding to α2A-AR under nucleotide-depleted conditions (A) 
derived from a single permeabilized cell transiently transfected as described in Table 6. (B) 
Off-rates of Gi3 (blue curve), and Go (pink curve) from α2A-AR were determined after 
withdrawal of 10 µM NA in the presence of 20 nM GTP and absence of nucleotides. Data are 
plotted as mean ± SEM. The traces were normalized to maximum (10 µM NA) and minimum 
(GTPγS). (C) Calculated dissociation kinetics (koff) for HEK293T cells transfected either with 
Go (n=9) or Gi3 (n=7) under nucleotide-free conditions are illustrated. Data are normalized to 
maximum (FYFP / FCFP ratio in presence of 10 µM NA) and minimum (FYFP / FCFP ratio upon 
final application of GTPγS) receptor occupancy state as depicted in Figure 39A. The values 
are shown as mean ± SEM. Significance level was determined by one-way ANOVA with 






4.1 The stability of mAChR-G protein complexes 
Understanding the molecular mechanism of selectivity and efficiency of receptor-
mediated G protein activation is one of the key research topics in the field of GPCR 
physiology and pharmacology. However, crystal structures of GPCR-G protein complexes do 
not resolve any common linear epitopes which could determine receptor selectivity for a 
particular G protein family (Rasmussen et al. 2011; Koehl et al. 2018). In this research, I have 
experimentally addressed the hypothesis that the specificity of G protein-receptor coupling 
depends on a complex three-dimensional interaction and might be specific for every receptor-
G protein pair. We therefore hypothesised that the degree of selectivity is dependent on the 
intrinsic affinity of the G protein to a particular receptor. Based on the fact that agonist-
receptor-G protein complexes exhibit the highest stability in absence of nucleotides 
(Christopoulos and Kenakin 2002; Roberts and Waelbroeck 2004), we quantified the affinity 
of different G proteins to M1-, M2-, and M3-Rs (Jürgen Wess 1998; Burford, Tobin, and 
Nahorski 1995; Kostenis, Zeng, and Wess 1998) by means of FRET imaging on 
permeabilized membranes of single cells. By laminar superfusion of these membranes we 
ensured excellent control of agonist and nucleotides (Figure 6, Figure 13) and resolved the 
dynamics of interactions between nucleotide-free G proteins with several different receptors. 
The ternary complex formation was defined as a high amplitude of response upon ACh 
application in permeabilized cells when compared to the small change in FRET signal 
measured in intact cells (Figure 6C). The minor increase in FYFP/FCFP ratio induced by agonist 
in intact cells was assumed to be a balance between G proteins bound to the receptor and the 
activated G proteins which have been dissociated from the receptor by GDP/GTP exchange. 
In contrast, in cells depleted from nucleotides by exposure to permeabilization agent and 
constant superfusion, the stimulation with agonist led to a higher amplitude of response and a 
slow decrease in FRET signal during agonist withdrawal confirming the formation of the 
ternary complex in absence of nucleotides und full receptor-G protein occupancy state (Figure 
6F). Although several previously published biochemical and radioligand-binding experiments 
suggest the inability to rescue the ternary complex without nucleotides, the re-exposition of 
the permeabilized cell to the agonist as depicted in Figure 6F results in repeating G protein 
recruitment to the receptor. One can argue, that this could indicate the unsustainable 
nucleotide depletion leading to binding of the previously activated and perhaps nucleotide-
free G proteins to the receptor. However, there are several observations against this argument. 
Firstly, the results show that even low concentrations of nucleotides lead to significant 
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changes in the receptor-G protein interaction dynamics (Figure 12, Figure 13), which makes 
the developed system rather nucleotide-sensitive. Although the multiple recruitment event of 
G protein to the receptor under agonist application can occur due to the excess of G proteins 
to the receptor (Figure 10), the amplitude of receptor-G protein interaction did not diminish 
substantially over the time course of the experiment. The excess of Gq-protein over M1-R or 
M3-R receptor was measured to be only 2-3-fold. Therefore, a loss of half of the G protein 
population after the first stimulation (assuming full receptor occupancy) should have led to, at 
least, a detectable reduction of the second amplitude compared to the first one, which was not 
observed. Secondly, as depicted in Figure 13 agonist-induced M3-R-Gq interaction subsequent 
to exposing the cell membranes to 100 nM GDP after an initial period of nucleotide 
withdrawal, resulted in a transiently enhanced receptor-G protein interaction signal compared 
to a second application of the same concentration of agonist. This can be best explained by 
GDP-binding being somewhat rate limiting under these conditions (100 nM), causing -still 
nucleotide-free- G proteins to bind to the receptor followed by the  release from the receptor 
due to receptor-induced GDP binding (Dror et al. 2015).  
The lifetime of receptor-G protein complexes was determined by measuring complex 
dissociation in response to withdrawal of agonist and was longest for those complexes that 
contained G protein subtypes that are known to be activated best by the respective receptor 
(Figure 7, Table 8). Since the active conformation of the receptor is maintained by the 
presence of the agonist, the determination of the association kinetics of G proteins to the 
receptor in the continuous presence of the agonist would be preferable in order to get direct 
access to the binding kinetics. Unfortunately, in current experimental settings with biological 
membranes it is impossible to add G proteins in a defined fashion. However, it has been 
shown, that kinetics of agonist binding to muscarinic as well as adrenergic receptors are 
considerably faster (Hoffmann et al. 2012; Vilardaga et al. 2003) than the binding of receptors 
and G proteins under current nucleotide free experimental conditions (τ value for about 0.1 s 
for M3-R activation with 1 mM CCh, and about 28 s for M3-R-Gq binding induced by 1 mM 
CCh under nucleotide-depeleted conditions) (Hommers et al., JBC 2010). The receptor-G 
protein dissociation kinetics were dramatically accelerated by applying nucleotides (Figure 
13). In accordance with known similar binding affinities of GDP and GTP for a given G 
protein, major differences in the dissociation rate of receptor G protein complexes upon GDP 
versus GTP application were not observed. Therefore, the performed analysis of dissociation 
kinetics of G protein receptor complexes is not affected by the activity state of the G protein 
and reflects exclusively the nucleotide free state of the G protein. It is also important to note, 
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that all signal-transducing GTP-binding proteins bind and hydrolyse GTP, properties that are 
crucial to their function as a molecular switch for diverse cellular functions. Each GTP-
binding protein, however, has its own dissociation constant for guanine nucleotides, Kd value 
for GTP and GDP, and rate constant for GTP hydrolysis (kcat.GTP) (Kaziro et al. 1991). One 
has to keep in mind, that ternary complex association includes at least 2 step pattern of the 
receptor-G protein interaction: initially GDP-loaded heterotrimeric G protein binding to the 
activate receptor and following after GDP release from the Gα subunit nucleotide-free G 
protein-receptor complex formation. The association kinetic of Gq and Go proteins with M3-R, 
which has been measured in the current nucleotide-free assay, is probably a mixture of those 
GDP-bound and nucleotide-free G protein-receptor interaction dynamics, since both were 
measured: initial low affinity phase of fast on-kinetics and high affinity state reached by the 
“empty” G protein-receptor complex after GDP release. Regarding Go-M3-R complex 
formation, the fast GDP dissociation from Go might affect the on-rate which could be a 
reason why I was unable to successfully fit the onset-kinetics to a monoexponential function 
(Figure 16). 
Preliminary data has provided further evidence that no replenishing GDP under current 
conditions occurs from the interaction of Gi family proteins with µ-OR (Figure 38). The µ-OR 
interaction with Gi proteins was quite stable (Figure 39), and had a tendency to form even in 
the absence of agonist under conditions of nucleotide depletion. In this context withdrawal of 
the agonist led to only a very slow receptor-G protein dissociation, however exposure to as 
little as 20 nM GTP accelerated the complex dissociation (Figure 40), suggesting the non-
existence of relevant concentrations of nucleotides in our preparation.  
In my studies I focused mainly on the dynamics of the receptor-G protein complex 
formation. Based on crystallography data (Rasmussen et al. 2011) receptors interact with G 
proteins by binding to the Gα subunits, whereas Gβγ subunits come in close proximity but 
without direct contact to any of receptor intracellular loops. However, the established FRET-
based assay cells were transiently transfected with C-terminus labelled receptor and the G 
protein labelled on the Gγ subunit. Since the insertion sites for GFP variants on Gα subunits 
differ substantially for the individual Gα subtypes, in order to achieve an accurate comparison 
between receptor-G protein coupling, the native Gα subunits were transfected. Importantly, 
only a very small signal due to endogenous Gα subunits (as a control pcDNA3 was 
transfected instead of Gα subunit) was observed, therefore high selectivity for transfected 
untagged Gα is guaranteed.  
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Moreover, the labelling of the Gγ2 subunit on its N-terminus with a flexible linker far 
away from the receptor-G protein interaction surface was chosen to minimize the influence of 
a fluorescent tag on Gα subunit interaction with the receptor. Nevertheless, in order to test 
whether the dissociation kinetics of fluorescent Gα subunits and M3-R will differ from those 
obtained with fluorescent Gγ2, additional experiments were performed. Despite having to deal 
with much lower FRET amplitudes by measuring FRET between YFP-labelled receptor and 
CFP-labelled Gα, association and dissociation kinetics of Gq and Go proteins to M3-R were 
very similar when either Gγ2 or respective Gα subunits were labelled (Figure 8). Furthermore, 
the robust expression of heterologously transfected G proteins was confirmed by means of 
Western Blot. No major differences in the expression levels of Gβγ were obtained when either 
Gαo or Gαq subunits were co-transfected (Figure 11).  
As has been mentioned in the introduction, only Gγ2 and Gβ1 subunits and no other 
isoforms were transfected as they are known to be not very selective in respect to heterotrimer 
formation with different Gα subtypes (Cook et al. 2001; Hillenbrand et al. 2015). However, 
influence of different Gβ and Gγ isoforms on the receptor-G protein complex stability can be 
an interesting topic for further investigation. 
One more interesting point for discussion is the preassembly of GPCRs and G proteins. 
Previous studies have reported basal FRET between some GPCRs and G protein subunits that 
may reflect some level of constitutive association or pre-coupling. One possible reason for 
agonist-independent receptor-G protein interaction is a specific anchoring mechanism such as 
described for the receptor C-terminus mediated tethering of M3 receptor and Gq proteins (Qin 
et al. 2011). The described mechanism of pre-coupling requires an unmodified C-terminus of 
the receptor, the described pre-association might be relevant physiologically, however it can 
be neglected under current study conditions since the receptor is labelled with YFP on the C-
terminus, which abolishes the described pre-association (Qin et al. 2011). Since pre-
association may enhance the probability of Gq activation over Go, the additional experiments 
were performed for both Go and Gq binding to M3-R under nucleotide depleted conditions 
applying GTPγS before the agonist. As no significant reductions in FRET signal under 
application of the GTPγS was observed, the phenomenon of pre-association of the G protein 
and the receptor in current studies was excluded (Figure 14). 
However, the comparable fast association of Go and Gq with M3-R could be connected to 
the intrinsic nucleotide exchange rates of the G proteins themselves. Although, it was not 
considered the intrinsic GDP release rates to be a major factor influencing M3-R-Gq and M3-
R-Go association and dissociation kinetics, this issue was experimentally tested. It has been 
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described that Gαo exhibits a about fourfold higher GDP release rate compared to Gαi2 
(Rubenstein, Linder, and Ross 1991), therefore Go and Gi2 steady-states binding to M3-R 
were compared. No significant differences were observed, as the obtained EC50 values (10.68 
± 0.32 µM and 8.33 ± 0.08 µM for Go and Gi2 respectively, Figure 15) were quite similar 
based on the approximately 2-fold difference in the complex dissociation rate (Table 8) and 2-
fold faster association rate for Go over Gi (Table 7).  
Unlike the dissociation kinetics of the nucleotide-free receptor-G protein complex, one 
has to be aware that steady-state and on-rate measurements might not exclusively be restricted 
to complexes after GDP release, but also include initially GDP-bound G proteins. GDP 
release is much faster for Go (Higashijima et al. 1987) than for Gq (Mukhopadhyay and Ross 
1999), which needs to be considered. Nevertheless, we attempted to measure the kon of 
GPCR-G protein interactions in native cell membranes. The correlation of apparent M3-R-Gq 
association kinetics and agonist concentration are consistent with a hyperbolic function 









 calculated by division of koff by the 
EC50 value (Figure 7D, Figure 17C), clearly indicating the applicability of our method. Based 
on the much faster equilibration kinetics of agonist binding to non-G protein bound 
muscarinic receptors (Hoffmann et al. 2012) the kinetics of agonist-induced receptor-G 
protein complex formation under nucleotide-free conditions is probably a close approximation 
to the optimal situation of G protein binding to equilibrated agonist-receptor complexes. In 
the case of M3-R-Go interaction, the correlation of apparent association kinetics of Go proteins 
and M3-R with the agonist concentration is best explained by a 2-component hyperbolic 
function (Figure 16). A comparison of the correspondingly determined on-rates with kon, 
(calculated based on koff and EC50 values) revealed, even with the slower on-rate, a 5-fold 
deviation from the calculated kon (Table 7). Possible reasons for this could be effects 
attributable to the above-mentioned multistep binding reaction. This might affect the apparent 
association kinetics of receptors and G proteins and complicates interpretation of the 
measured kon rates.  Therefore, at the current research stage, measuring the off-rates of the 
complex together with steady-state association gives a more robust quantitative correlate of 
the affinity of the subtype specific receptor-G protein complex. However, the association rate 
of the G protein and the receptor in our FRET assay could also be affected by the expression 
levels of the proteins. Therefore, as previously mentioned, the relative expression levels of 
fluorescent receptor versus fluorescent G protein were measured. Although in all cases only a 
2-6-fold excess of G protein versus receptor was observed (Figure 10), the difference in the 
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relative expression of the different G proteins for each receptor tested was at most approx. 2-
fold (Figure 10), which excludes a major influence of the expression ratio on the measured 
kinetics. Thus, based on theoretical considerations the expression ratio of receptor versus G 
protein should not affect the dissociation of the complex.  
The results of my research project show that both the steady-state curves of G protein 
binding to the M3-Rs as well as the dissociation kinetics of this complex quantitatively reflect 
M3-R-G protein selectivity (Table 7, Table 8, Figure 17). Specifically, the dissociation 
kinetics of Go protein from M3- and M1-Rs were 13-fold faster in comparison to Gq (Figure 7, 
Figure 18, Figure 19). Similarly, I have observed an approximate 16.5-fold right-shift of the 
concentration-response curves of Go proteins binding to M3-R in comparison to Gq (Figure 
17A). A quantitatively similar 6.6-fold difference in coupling efficiency of Go and Gq to M3-
R, measured in a FRET-based G protein activation assay in intact cells (Figure 17C), suggests 
that the efficacy of coupling to a certain G protein subtype is indeed reflected in the relative 
M3-R-G protein affinity, and can thus be detected by measurement of the lifetime of the G 
protein-receptor complex. For moderate to low affinity agonists with different efficacies we 
could so far not detect any differences in the stability of M3-R-Gq or Go complexes. The effect 
of ligands on the dynamics of G protein-receptor interaction has been additionally 
investigated and the findings are discussed in more details in section 4.3. An important 
finding was that the Gq-coupled and evolutionary close M1- and M3-Rs were found to be very 
similar in respect to their ternary complex stabilities and selectivity pattern for the different G 
protein subtypes (Figure 18, Figure 19, Table 8). Remarkably, the stability of the GPCR-G 
protein complexes varied over at least two orders of magnitude for the different receptors, 
being lowest for M2-R-Go protein complexes (lifetime only a few seconds, Table 8) and 
highest for TP-R-G13 complexes and β-AR-Gs complexes (lifetime > 200 s, Figure 32, Figure 
30), which likely reflects the parallel evolution of the coupling mechanism (Flock, et al., 
2017). In light of recent advances in understanding the allosteric effect of G protein binding 
(or mimicking nanobodies) to the M2-R-agonist interaction, specifically the closure of a 
tyrosine lid on the extracellular side of the agonist exit path (Haga K, et al., 2012; Kruse AC, 
et al., 2013; DeVree BT, et al.,2016), the results that M2-R-Go interaction is very short lived 
may be somewhat unexpected. However, they are not contradictory to published results, as 
the lifetime of M2-R-Go complexes were not addressed in previous studies. The reliability of 
the method we developed was also confirmed by testing other G protein classes. For instance, 
I was unable to detect Gs or G13 binding to M3-R or M1-R under nucleotide-depleted 
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conditions (Figure 7A), or to observe activation of these G proteins measured by means of 
FRET (Figure 9A,C).  
Furthermore, other Gi family proteins were screened, and although no significant 
differences in the affinities of Gi proteins to M3- or M1-Rs could be observed, M2-R did show 
a higher specificity for Go and Gi2 over Gi1 and Gi3 (Figure 18B, Figure 19D, Figure 20D). 
This distinct affinity profile of GPCR is also supported by recently delineated GPCR 
fingerprints determined as the efficiency of G protein activation by different GPCRs (Carr III 
R, et al. ,2015). Moreover, recent computational and evolutionary studies assume that the 
selectivity mechanism of GPCRs is likely disclosed on the G protein level (Flock, et al.,2015; 
Flock, et al.,2017). Thus, one can conclude that receptor-G protein affinity represents a major 
determinant for receptor-G protein subtype selectivity. The observed differences in the 
affinity of Go vs Gq towards active M3-Rs can be essentially attributed to the differences in the 
lifetime of the complex, suggesting that the apparent on-rate of complex formation is less 
important for defining coupling selectivity.  
The potential and distinctive advantage of our FRET-based nucleotide-free method over 
biochemical assays is the ability to perform experiments in a regular membrane environment. 
By excluding the steps of protein purification and protein reconstitution (Lee, Linder, and 
Gilman 1994; M E Linder et al. 1990) a remarkably high degree of signal specificity is still 
exhibited. This is particularly important as G proteins are well known to be very sensitive to 
detergents (Sýkora, 2009). Furthermore, this method is easily accessible to all GPCRs and G 
proteins and can be used as a reliable way to quantify GPCR-G protein specificity. 
The calculation of the kon based on the equation E3 was done based on steady-state 
experiments on G protein binding to M3-R under nucleotide-depleted conditions. We assumed 
that the EC50 of these dose-response curves reflected the Kd values since the amplitudes of the 
YFP/CFP intensities ratio reflect the occupancy of the active M3-Rs by nucleotide-free G 
proteins bound with a high affinity under application of different agonist concentrations.  
Taken together, the performed detailed analysis of M3-R revealed that the lifetime of the 
nucleotide-free GPCR-G protein complex rather than the association kinetics is the major 
determinant for the differences in affinity of these complexes. 
4.2 Insights of G protein-receptor selectivity mechanism  
Taking into account that receptor-G protein complex stability depends on intracellular 
nucleotide concentration (Matesic et al. 1989) the ability of Gαi protein to bind relative GPCR 
after modifying the C-terminus of Gαi subunit by Pertussis toxin was tested. The FRET 
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method described above in combination with the controlled nucleotide concentrations 
technique was used to address this issue. 
In this part of my research project I have focused on M2 and M3 muscarinic acetylcholine 
receptors and additionally on α2A adrenergic receptor, as GPCRs known to activate inhibitory 
G proteins. According to the recent computational experiments, the interaction of µ-OR with 
Gi protein is a multistep process which involves first low affinity contact as initial recognition 
phase followed by high affinity binding of G protein to the receptor (Sounier et al. 2015). The 
aim of the study was to reveal the involvement of the α5 C-terminus of the Gα subunit in the 
selectivity of receptor-G protein interaction. Pertussis toxin was used to covalently modify the 
last amino acids of the Gαi subunit in order to prevent coupling to the receptor (Quist, 
Satumtira, and Vasan 1999). The binding Gi proteins to M3-R and to α2A-AR under 
nucleotide-depleted conditions as well as their activation was completely abolished in cells 
treated with PTX (Figure 21). Although inhibition of Gi with Pertussis toxin might indicate 
the complete blockage of G protein-receptor binding, it is also possible to suggest that α5 C-
terminus of Gi binding to H8 and ICL1 domains of the receptor plays a crucial role in the 
mechanism of G protein-receptor selectivity and might be the first step in G protein-receptor 
low-affinity contact. 
4.3 Alterations in ternary complex stability induced by different ligands  
Previously in this study, I investigated whether the selectivity of the receptor-G protein 
interaction depends on intrinsic affinity of the G protein to the receptor. It was also of great 
interest to test the influence of agonist on ternary complex stability using the mAChR-G 
protein complex model. As no difference in the ternary complex stability was observed when 
the receptor-G protein binding was induced by agonists with several fold differences in 
affinity to the receptor such as ACh, CCh or Are (Figure 23), it was concluded that agonist 
affinity does not affect ternary complex stability once it is formed. However, we extended our 
studies on the complex stability by also comparing agonists with different efficacies to 
activate mAChRs. Taking into account that stimulation of M3-R with partial agonists such as 
pilocapine or choline evoked rather small amplitudes in FRET signal, further detailed 
experiments were done analyzing the M1-R-Gq interaction. Interestingly, the ligand specific 
differences in the dynamics of M1-R-Gq complex formation were rather observed for the 
association kinetics than for the dissociation of the G protein from the receptor (Figure 23). 
These data suggest that the efficacy but not affinity of the ligand to the receptor influence the 
speed of ternary complex formation in absence of nucleotides. Indeed, in the range of the 
agonists, tested in this part of my project, the row of ligands ordered by the kon values of the 
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M1-R-Gq complex (Table 9) correlated with the ability of the respective agonist to activate G 
proteins (Figure 24). Therefore, it is assumed that calculated kon values reflect the probability 
of the receptor to be stabilized in active conformation by a particular ligand. Thus, the 
established method can further help to quantitatively characterize the degree of partial 
agonism of different pharmacological agents.  
Moreover, I have tried to assess the contribution of allosteric modulators to the ternary 
complex stability. It was shown, that at least in case of BQCA the positive allosteric effect 
occurs due to the change in BQCA-agonist-induced efficiency of G protein coupling rather 
than alteration of ligand affinity to the receptor (Figure 26, Figure 27). Although, negative 
allosteric modulator Gallamine did not affect M1-R-G protein complexes stability, the 
additional experiments such as steady-state measurements and kon kinetics calculation should 
be done. 
4.4 Quantification of high affinity GPCR-G protein complex stability 
In order to investigate whether the correlation of mAChR-G protein complex stability 
with receptor-G protein selectivity can be expanded for other GPCRS, in this part of the 
research project I studied the dynamics of G protein interaction with thromboxane 2A 
receptor, α2A-, β1-, and β2-adrenergic receptors, as well as with ETBR - and µ-ORs. In all cases 
we observed that the receptors bind with the highest affinity (reflected in the longest lifetime 
of the complex) to those G proteins that are known to be activated best by the respective 
receptor. The complexes of Gs-β1-AR and Gs-β2-AR as well as TP-R-G13 (Figure 29, Figure 
30, Figure 32) were found to be very stable and therefore their dissociation rate was too slow 
to be quantified by fitting an exponential curve. For some receptors such as the β1- and β2-
ARs and µ-ORs the basal activity and the long lifetime of the receptor-G protein receptors 
complex did not allow for an accurate determination of the lifetime of the complex, however 
until now, all data on the receptor-G protein lifetime of our measured receptor-G protein 
complexes are in line with the generalization proposed in Ilyaskina et al., 2018 Even though 
all the novel data correlate with the assumption that the conclusions of our in depth study on 
muscarinic receptors can be generalized, this generalization requires testing of many more 
members of different GPCR families.   
It was hypothesized that Gi family proteins might have various affinities to µ-OR due to 
the differences in their structural homology. In this study I have particularly focused on Go, 
Gi1 and Gi2 proteins. In previous experiments on permeabilized cells it was shown that these 
proteins form very stable ternary complexes (agonist-receptor-G protein) with µ-OR under 
application of DAMGO. Therefore, we decided to use constant GTP concentration to 
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modulate the dissociation rate of G protein from the receptor during the agonist removal. This 
allowed us to calculate the koff for each tested G protein. The sufficient concentration of GTP 
to depict the differences in dissociation kinetics was empirically established (data not shown). 
The defined relative affinities of Go, Gi1 and Gi2 to µ-OR were found to be similar. However, 
the pattern of higher Go affinity to µ-OR compared to other G proteins might obtain the higher 
significance level if more experiments were performed, which would correlate with the Go 
properties described in literature (Oldham et al., 2008). The complexity of the experimental 
protocol is also increased by membrane permeabilization procedure as well as the instability 
of GTP under room temperature in the perfusion system. 
Interestingly, the initial application of GTPγS led to a decrease in FRET signal, indicating 
for the agonist-independent G protein – receptor complex formation directly after 
permeabilization. This effect can be explained by the high affinity of Gi family proteins to µ-
OR and their ability to couple to the receptor in absence of agonist under GTP-free 
conditions. Although, the rate of association kinetics did not differ within the group of tested 
G proteins, significant differences in the amplitude of the decrease in FRET signals under 
application of GTPγS was observed. In contrast to Gi1, Go and Gi2 were observed to form 
more stable complexes with µ-OR as GTPγS triggered a larger decrease of FRET reflecting a 
larger fraction of G protein occupied receptors prior to dissociation. In order to diminish 
agonist-independent µ-OR-Gi protein complex formation prior to permeabilization, cells can 
be incubated with µ-OR antagonists to such as naloxone. 
To sum up, the established FRET assay on permeabilized cells is applicable for 
quantification of GPCR-G protein selectivity for the G proteins with high intrinsic affinity. 
The differences in the dissociation kinetics of Gq, G13 and G12 proteins from TP-R in the 
presence of 25 nM GTP correlated with steady-state experiments under GTP-depleted 
conditions measured by means of FRET (Figure 32, Figure 33). Interestingly, relative 
affinities for Gq and G12 were found to be similar. Moreover, the acceleration of relatively 
slow Gi3 and Go dissociation rates from α2A-AR revealed a significant difference in Gi3 and Go 
binding affinities to α2A-AR (Figure 42). 
Although, modulation of μ-OR-Gi family proteins complex stability by 20 nM GTP 
concentration did not reveal any significant difference between Gi family members, the 
calculation of the amplitude of the FRET decrease under application of GTPγS could be 
useful for the assessment of the stability of the ternary complex (Figure 40, Figure 41). 
Similar to experiments with mAChRs, it would be interesting to investigate the stability 
of high affinity G protein-receptor complexes in dependence of receptor agonists with 
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different properties. For instance, it would be interesting to compare the Gi family members 
affinity to µ-OR under application of partial agonists such as morphine and buprenorphine 
and investigate dissociation kinetics of G13-, G12-, and Gq-TP-R in respond to daltroban 
(Figure 37). Also, the modulation of G protein-receptor dissociation rate by low GTP 
concentration can be used to elucidate the differences in Gs-β adrenergic receptors complexes 
stability induced by various ligands. 
 
In summary, the FRET-based method developed in my research work allows to quantify 
the degree of G protein-receptor complex stability in a regular membrane environment. Using 
this approach, I have shown that the intrinsic G protein affinity is a major determinant of the 
receptor-G protein selectivity for different receptor families. Moreover, screening over 
different GPCR ligands revealed the certain pattern of G-protein-receptor ternary complex 





G protein coupled receptors (GPCR) regulate many important physiological functions 
by converting extracellular stimuli into the variety of biological responses. The spectrum of 
induced signalling pathways depends on the type of heterotrimetric G protein coupling to the 
receptor. A number of recent structural and computational studies could visualize and define 
motifs important for G protein-GPCR complex formation. However, the essential factor for 
the receptor-G protein selectivity has not been fully elucidated. In this research project it was 
hypothesized that G protein-receptor selectivity can be determined by G protein affinity, 
which can be numerically assessed as ternary complex stability. 
Interaction of G protein with the receptor can be subdivided into three major phases: G 
protein binding to the ligand-activated receptor, nucleotides exchange (GDP to GTP) on the 
Gα subunit which leads to ternary complex formation (ligand-receptor-G protein), and finally 
activation of the heterotrimeric G protein resulting in rearrangement of Gα and Gβγ subunits.  
Taking into account that ternary complex is stable only in the absence of nucleotides, I have 
developed a broadly applicable FRET-based assay to study receptor-G protein interaction in 
permeabilized transiently transfected cells under nucleotide depleted conditions. This 
approach allowed to quantitatively as both association and dissociation rates of G proteins 
from agonist-activated GPCRs.  
Activated by similar agonists, members of muscarinic acetylcholine receptor family 
(mAChRs) have been known to couple to different G protein classes. Therefore, mAChRs 
were taken as a model to study GPCR-G protein selectivity. G protein affinity was calculated 
as dissociation kinetics in response to withdrawal of agonist. Remarkably, the dissociation 
rate was the slowest for those complexes that contained G protein subtypes that are known to 
be most efficiently activated by the respective receptor. Specifically, dissociation of Gq 
protein from M3- and M1-Rs was significantly slower in comparison to Go, Importantly, the 
shift in concentration-response curves in steady-state experiments correlated well with the 
calculated Gq and Go affinities. Moreover, G protein activation measurements revealed 
quantitative correlation between coupling efficiency and affinity of Go and Gq to M3-R. This 
suggests that the stability of the receptor-G protein complex is an inherent property of both 
interaction partners and closely correlates with the ability of the receptor to activate the 
corresponding G protein subtype. In addition, by calculating the constants of association and 
dissociation, it has been shown that the affinity of the G protein to the receptor, but not the 
rate of ternary complex formation, determines the degree of GPCR-G protein selectivity. 
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Apart from mAChRs, this principle was also applicable for other GPCRs: µ-OR, β1-, 
β2-, and α2A-adrenegic receptors, TP-R and ETRB. Interestingly, each receptor revealed an 
individual pattern of G protein affinities. It was also observed that receptors known for high 
basal activity form extremely stable complexes with their regular interacting G proteins. The 
characterization of G protein affinities spectrum for such GPCRs was challenging. In this 
case, in order to quantify the ternary complex stability, the dissociation rate was modulated by 
the addition of constant low GTP concentrations. Thus, it was possible to show the difference 
between the affinities of individual members of G protein families. 
Moreover, the developed nucleotide-free method was used to test a range of 
orthosteric and allosteric mAChRs agonists with different affinities and efficiencies in terms 
of ternary complex stability. It was shown that the efficiency, but not the affinity, of the 
ligand to the receptor can be estimated as the rate of GPCR-G protein complex association. 
Calculated constant of association correlated with the efficiency of G protein activation and 
reflected the probability of the receptor to be stabilized in the active conformation by the 
particular agonist. Interestingly, the results of FRET experiments on permeabilized cells 
correlated with the data derived from FRET measurement on membranes. The last technique 
can be further used as a cell-free screening of different pharmacological agents effecting 
GPCR-G protein dynamics. 
To conclude, my findings shed new light on the mechanisms which determine the 
receptor-G protein selectivity. 
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G-Protein-gekoppelte Rezeptoren (GPCR) regulieren viele wichtige physiologische 
Funktionen, indem sie extrazelluläre Stimuli in eine Vielzahl biologischer Reaktionen 
umwandeln. Das Spektrum der induzierten Signalwege hängt von der Art der 
heterotrimetrischen G-Protein-Kopplung an den Rezeptor ab. Eine Reihe von aktuellen 
strukturellen Studien und Computersimulationen ermöglichte die Visualisierung und 
Bestimmung von Motiven, die für die Bildung von G-Protein-GPCR-Komplexen wichtig 
sind. Der wesentliche Faktor für die Rezeptor-G-Protein-Selektivität wurde jedoch nicht 
vollständig aufgeklärt. In diesem Forschungsprojekt wurde die Hypothese aufgestellt, dass die 
Rezeptor-G-Protein-Selektivität durch die G-Protein-Affinität bestimmt wird, die als Stabilität 
des ternären Komplexes quantifiziert werden kann. 
Die Interaktion eines G-Proteins mit einem Rezeptor kann in drei Hauptphasen 
unterteilt werden: G-Protein-Bindung an den ligandenaktivierten Rezeptor, 
Nukleotidaustausch (GDP zu GTP) an der Gα-Untereinheit, was zur Bildung des ternären 
Komplexes führt (Ligand-Rezeptor-G-Protein) und schließlich Aktivierung des 
heterotrimeren G-Proteins, was zur Umlagerung von Gα- und Gβγ-Untereinheiten führt. Unter 
Berücksichtigung der Tatsache, dass der ternäre Komplex nur in Abwesenheit von 
Nukleotiden stabil ist, habe ich einen breit anwendbaren FRET-basierten Assay entwickelt, 
um die Rezeptor-G-Protein-Interaktion in Abwesenheit von Nukleotiden zu untersuchen. 
Dieser Ansatz ermöglichte die quantitative Abschätzung sowohl der Assoziations- als auch 
der Dissoziationsrate von G-Proteinen aus durch Agonisten aktivierten Rezeptor-G-Protein-
Komplexen. 
Es ist bekannt, dass Mitglieder der muscarinischen Acetylcholin-Rezeptor-Familie 
(mAChRs), die von ähnlichen Agonisten aktiviert werden, an verschiedene G-Protein-Klassen 
koppeln. Daher wurden mAChRs als Modell zur Untersuchung der GPCR-G-
Proteinselektivität herangezogen. Die G-Protein-Affinität wurde als Dissoziationskinetik der 
Reaktion auf den Entzug des Agonisten berechnet. Bemerkenswerterweise war die 
Dissoziationsrate für jene Komplexe am langsamsten, die G-Protein-Subtypen enthielten, von 
denen bekannt ist, dass sie vom jeweiligen Rezeptor am effizientesten aktiviert werden. 
Insbesondere war die Dissoziation des Gq-Proteins von M3- und M1-Rs im Vergleich zu Go 
signifikant langsamer. Wichtig ist, dass die Verschiebung der Konzentrations-Reaktions-
Kurven in stationären Experimenten gut mit den berechneten Gq- und Go-Affinitäten 
korrelierte. Darüber hinaus zeigten G-Protein-Aktivierungsmessungen eine quantitative 
Korrelation zwischen der Kopplungseffizienz und der Affinität von Go und Gq zu M3-R. Dies 
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deutet darauf hin, dass die Stabilität des Rezeptor-G-Proteinkomplexes eine inhärente 
Eigenschaft beider Interaktionspartner ist und eng mit der Fähigkeit des Rezeptors korreliert, 
den entsprechenden G-Protein-Subtyp zu aktivieren. Zusätzlich wurde durch Berechnung der 
Konstanten der Assoziation und Dissoziation gezeigt, dass die Affinität des G-Proteins zum 
Rezeptor, jedoch nicht die Bildungsrate des ternären Komplexes den Grad der GPCR-G-
Protein-Selektivität bestimmt. 
Außer mAChRs galt dieses Prinzip auch für andere GPCRs: µ-OR-, β1-, β2- und α2A-
adrenegische Rezeptoren, TP-R und ETB-R. Interessanterweise zeigte jeder Rezeptor ein 
individuelles Muster der G-Protein-Affinitäten. Es wurde auch beobachtet, dass Rezeptoren, 
die für ihre hohe Basalaktivität bekannt sind, mit ihren regulär interagierenden G-Proteinen 
extrem stabile Komplexe bilden. Die Charakterisierung des G-Protein-Affinitätsspektrums für 
solche GPCRs war schwierig. In diesem Fall wurde zur Quantifizierung der ternären 
Komplexstabilität die Dissoziationsrate durch Zugabe konstant niedriger GTP-
Konzentrationen moduliert. Somit konnte der Unterschied zwischen den Affinitäten einzelner 
Mitglieder von G-Protein-Familien gezeigt werden. 
 Darüber hinaus wurde die entwickelte nukleotidfreie Methode verwendet, um eine 
Reihe von orthosterischen und allosterischen mAChRs-Agonisten mit unterschiedlichen 
Affinitäten und Effizienzen hinsichtlich der Stabilität des ternären Komplexes zu testen. Es 
wurde gezeigt, dass die Effizienz, aber nicht die Affinität des Liganden zum Rezeptor, als 
Rate der GPCR-G-Proteinkomplexassoziation abgeschätzt werden kann. Die berechnete 
Assoziationskonstante korrelierte mit der Effizienz der G-Protein-Aktivierung und spiegelte 
die Wahrscheinlichkeit wider, dass der Rezeptor durch den jeweiligen Agonisten in der 
aktiven Konformation stabilisiert wird. Die Ergebnisse von FRET-Experimenten an 
permeabilisierten Zellen korrelierten mit den Daten, die aus der FRET-Messung an 
Membranen erhalten wurden. Die letzte Technik kann ferner als ein zellfreies System für 
Screening verschiedener pharmakologischer Wirkstoffe verwendet werden, die die GPCR-G-
Proteindynamik beeinflussen. 
Zusammenfassend werfen meine Ergebnisse ein neues Licht auf die Mechanismen, die 
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